Podcasts about Calcium

Your blood pressure medication may be lowering one of the very nutrients needed to support healthy blood pressure. Discover what causes high blood pressure and why your blood pressure won't go down, despite treatment. 0:00 Why your high blood pressure won't go down0:20 Thiazide diuretics and magnesium depletion 1:48 Calcium channel blockers 2:16 Magnesium and potassium 4:12 Vitamin D deficiency and hypertension 5:27 What causes high blood pressure?7:56 Sodium and high blood pressure 8:53 How to lower blood pressure This video is for educational purposes only, not medical advice. Do not start, stop, or change medication without your physician.

Welcome back to our weekend Cabral HouseCall shows!   This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track!   Check out today's questions:    Lena: Hi Dr. Cabral, I absolutely love your podcast and listen to it every day! Thank you for everything you do to make us all healthy! My question is, how do you feel about taking supplements for 5 days and then not taking them for 2 days? Is this good for the body or is better to take them every day? Thank you so much!      Hilary: Hi Doc, Thank you for sharing your knowledge and wisdom with all of us! I recently started going to a biological dentist. He said that my gums are inflamed and gave me an ozone treatment. Is there a root cause or a way to find a root cause for inflamed gums?      Mohamed: Hello Dr.Cabral.. Ive been a daily viewer of your podcast for a few years now.. really struggling. I've watched all your blood pressure videos. Tried everything to lower my dad's Bp. Magnesium, Omega 3, DNS. To no avail. Ive also tried to increase his potassium. It's frustrating.. he takes a combo of Amplodine (CC blocker and Telmisartan ARB) Even that doesn't help.. what do you recommend. He did his minerals and metals lab. Potassium was green, sodium was borderline yellow at 11. Magnesium was a 5 (exactly green). Calcium 66 (green but close to orange). Ca/Mg ratio is high. Ca/K ratio which is elevated. Na/Mg is low. One thing we haven't tried was proteolytic enzymes.. honestly I think it's hardening of Arteries. He's late 60s. Thanks Doc       Karen: Hi, Dr. Cabral I have a lot of health issues: POTS, MCAS, very very low HRV, extreme postprandial heart elevation after eating, extreme fatigue, Ehlers Dahlos/hyper mobility. I saw a functional medicine doctor to try to get on a good health track but it became focused on elimination diet which became too extreme for me because I have a history of an eating disorder. (almost 10 years ago but still, I was losing too much weight for it to be healthy for me) Please advise where to start and if it is possible to get on track without doing elimination diet. Thank you!       Aidan: Hi Dr Cabral, roughly 9 months ago I was sick with mono for about 6 weeks. As my symptoms eased I began to notice a lot of tingling and numbness in my limbs, 90% in the left arm. As I returned to fitness and the feeling went away I found my pressing strength in the left side was very diminished. My tricep, left upper pec, and left lat lost a lot of size and I was unable to load them anywhere close to where I could prior. I went to the a neurologist and it was revealed through EMG I have a pinch in my elbow and neck. It is also suspected that I could have some kind of post viral neuropathy as ever since then I do experience lots of weird tingling in my arms and sometimes legs as well as the strength defect and I am struggling to get back. Looking for any advice, I feel like I'm losing hope       Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3788 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

On this episode of Vitality Radio, Jared shines a spotlight on boron, one of the most overlooked minerals in human nutrition and a nutrient with surprising implications for bone health, hormone balance, vitamin D activity, and healthy aging. A major focus of this episode is osteoporosis prevention and bone density support, including why simply taking more calcium may not be the answer. Jared explores the science behind boron's role in calcium retention, magnesium utilization, vitamin D metabolism, and healthy bone formation while also discussing the importance of key bone-building cofactors like vitamin K2, silica, and magnesium. He breaks down the research on osteoporosis, osteopenia, and the "calcium paradox," while explaining how boron may support healthy hormone levels, cognitive function, joint comfort, and overall wellness. If you're concerned about aging well, maintaining strong bones, or optimizing your health naturally, this episode is a must-listen.Products:Vital D3/K2 High PotencyVital D3/K2Solaray Calcium HydroxyapatiteMagnesium Bisglycinate Ultimate Vitality MultiHakala Labs BoroTabVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In this episode, Leslie Fuller, ND focused on the often-overlooked musculoskeletal symptoms experienced by women during perimenopause and menopause. She discusses strategies for effective management, including nutrition, resistance training, hormone assessment, and addressing both structural and functional health. This episode offers healthcare professionals and patients evidence-based approaches to support musculoskeletal health through the menopausall transition.Enroll now in: Under-Recognized, Under-Treated, and Misrepresented Realities of the Perimenopause and Menopause Transition, with Leslie Fuller, ND and Jillian Moehle, ND at https://pages.kharrazianinstitute.com/fuller-moehle-perimenopause00:00 Menopause-related musculoskeletal issues06:32 Assessing musculoskeletal conditions10:25 Identifying osteoporosis risk factors13:48 Comprehensive management for inflammation repair15:07 Discussing menopause and bone health18:48 Future FDA approval and nutrition strategies24:30 Effects of Isoflavones and Lignans25:40 Calcium and vitamin D benefits31:14 Creatine and CoQ10 for muscle health33:42 Importance of aerobic and resistance training38:13 Combating sarcopenia through referrals39:17 Screening for menopausal musculoskeletal syndromeSupport this show http://supporter.acast.com/solving-the-puzzle-with-dr-datis-kharrazian. Hosted on Acast. See acast.com/privacy for more information.

Hosts: Ed Jones (Owner of Nutrition World) & Clint Powell A variety of topics all to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: All about Eggs & Pasture Raised Chickens with Kristy, Deprescribing & “De-Supplementing” with Dr. Curt Dearing [0:00:00] Intro, Nutrition World Updates, and Ed's Bodybuilding Prep Ed announces a new partnership with Azure: Bringing ~100 new holistic food items into Nutrition World. Examples: maple syrup, coconut oil, apple cider vinegar, organic chicken breast, cheeses, farm butters. Ed shares he's preparing for the Chattanooga Fitness Bodybuilding Contest (his 4th year): Being coached by Matt Davis (Train Station gym). Current approach: high protein, ~40% fewer calories, focused fat loss. Matt had him do a high-carb refeed day (~300g carbs vs his usual 50g) which dramatically improved his energy and look. [0:9:11] Protein, Longevity, and Why Ed Focuses on Eggs Ed emphasizes a higher-protein diet, especially for aging, muscle maintenance, and longevity. Core diet elements he advocates: Higher protein Healthy fats Colorful vegetables (in smaller but consistent amounts) Notes many women under-consume protein, which accelerates muscle loss and impacts longevity. Introduces guest Kristy, a long-time friend and staff member who homesteads and raises eggs that Ed eats 12–18 per week. [0:11:04] Homesteading with Kristy: How She Raises Chickens and Protects the Flock Kristy's setup: Around 100 chickens, plus goats, dogs, cats, and a donkey (Bradford). Lives “on the prairie” (rural, wooded property). Uses no chemicals on the property (no weed killers, pest sprays, etc.). She wants chickens to “do chicken things”—roam, peck, eat bugs, move soil—rather than be treated like pets or indoor animals. Predator control: No perimeter fence; previously lost some chickens to a fox attack. Now uses Bradford the donkey and a Great Pyrenees dog for protection: Donkey alerts and deters daytime predators like hawks and owls (stomping and loud calls). Pyrenees patrols at night, primarily deterring coyotes. Roosters herd hens into cover when threats appear. Motivator: Kristy's passion for knowing where her food comes from, and controlling at least part of her family's food system. [0:15:09] Structured Water, and Animal Hydration Kristy filters all animal water with a high-grade system (not just a basic fridge filter): Removes contaminants without completely stripping all minerals (not full RO). Then she “restructures” the water with a swirling device (structure unit): Mimics water flowing over rocks in nature, believed to add “life” and energy back to the water. She and Ed both report feeling better hydration from structured water (less persistent thirst). All of her animals receive this filtered/structured water. [0:17:26] Egg Production, Breeds, and Why Yolk Color Matters Kristy keeps multiple chicken breeds: Shell color = breed, not nutrition (white, brown, cream, etc., are just different breeds). Example: White Leghorn → white eggs, Rhode Island Red → darker brown eggs. Key nutritional indicator: yolk color She aims for deep orange yolks. Pale yellow yolks signal lower nutrient density, especially protein and nutrient intake from the chickens' diet. Production basics: Most hens lay about 5–6 eggs per week, especially in their first 3 years. Ed and Clint estimate she's getting hundreds of eggs per week in total. Kristy's flock policy: She has a “no-kill” policy for older hens, keeping them for tick and bug control and the social flock structure. Acknowledges some people cull flocks after 2–3 years, but she tends to keep productive, healthy hens past 4 years. [0:19:37] Industrial Eggs vs. Pasture-Raised: Animal Welfare and Nutrition Ed contrasts Kristy's setup with CAFO operations (Concentrated Animal Feeding Operations): Chickens crowded in small cages, poor conditions, bad feed. Notes such operations often use antibiotics—partly for disease, but also because they fatten animals. Kristy's holistic management: No antibiotics; uses natural anti-parasite and immune support: Pumpkin seeds for worms Homegrown herbs like oregano and rosemary She builds a strong “terrain” (internal environment) in the animals so they resist disease better. Discussion that what chickens eat (seed oils, moldy grains, etc. in industrial systems) ultimately affects the nutritional quality of the eggs humans eat. Nutritional highlights of eggs: Choline in yolks (brain and cognitive health). A “perfect protein” with high biological value and broad micronutrients. Eggs historically rank at the top for turning dietary protein into muscle due to a complete amino acid profile. Cholesterol discussion: Ed challenges the blanket fear of cholesterol: Cholesterol supports hormone production and brain function. Notes that the real risk markers are advanced lipoproteins like ApoB and Lp(a), not total cholesterol alone. Personal example: Ed eats 12–18 eggs per week. & his cholesterol is extremely low by clinical standards. Conclusion: Quality eggs are encouraged, especially from pasture-based systems like Kristy's, or higher-quality options in stores. [0:23:15] “Organic” vs. “Pasture-Raised” and Misleading Egg Labels “Organic eggs”: fed organic feed but may still be confined indoors with no outdoor access. “Pasture-raised”: hens are outdoors on pasture, doing natural chicken behaviors; often superior in welfare and nutrition. Both agree: If forced to choose, pasture-raised is preferable to organic-only. They call out labels bragging about “vegetarian-fed” hens as misleading: Chickens are not natural vegetarians; they're omnivores that eat bugs. Forcing a vegetarian diet moves them away from their natural food and may reduce egg quality. Kristy shares a quirky but natural behavior: Chickens love scrambled eggs as a treat. She feeds them scrambled eggs and crushed shells. Rationale: Eggshells are rich in calcium, which hens need to build strong new shells. She simply cracks and throws shells; no elaborate processing.. [0:27:25] Refrigeration vs. Room-Temperature Egg Storage Kristy's explanation: Freshly laid eggs have a “bloom” or natural protective coating that makes them shelf-stable if not washed. Unwashed farm eggs can sit at room temperature for ~6 weeks or more. Store-bought eggs are washed and must be refrigerated, because washing removes that protective coating. You cannot safely leave standard grocery-store eggs on the counter. Ed highlights this as another example of nature's built-in protective design. [0:32:28] Deprescribing and “De-Supplementing” with Dr. Curt Dearing Ed reintroduces Dr. Curt Dearing to expand on a prior show about deprescribing (reducing excessive medications). Common scenario Curt sees: People on many prescription meds plus a large number of supplements, overwhelmed and confused. They want to simplify, optimize, and know what really matters. Curt's consult approach: Review all meds and all supplements, then: Remove what isn't necessary. Emphasize foundational lifestyle and core supplements. They warn about a false sense of security: Some people think “I'm taking a pill, so I don't have to change my habits.” This applies to both pharmaceuticals and nutraceuticals. [0:36:00] The Core Four, Lifestyle First, and Limits of Medication-Only Approaches Ed references his “Core Four” foundational supplements (detailed in a free ebook on The Holistic Navigator): Designed as tier 1 essentials vs. lower-tier “nice-to-have” supplements. Curt's stance: Diet and exercise are the primary pillars. Supplements should support, not replace, healthy habits. Example: People on metformin or berberine may keep eating poorly yet feel “covered” because their blood sugar numbers look better. This is managing symptoms, not addressing root causes. [37:15] “Beyond Cholesterol” and Advanced Heart Risk Testing Curt mentions his upcoming ebook “Beyond Cholesterol” (targeting Amazon release): Argues standard lipid panels (total cholesterol, LDL, HDL) are not enough. Advocates for advanced tests like ApoB, Lp(a), and coronary calcium scores. Example case: A patient with LDL of 212 on atorvastatin. Curt notes that LDL alone can be “dangerous or harmless” depending on the underlying particle types and inflammation. Coronary Calcium Score: Patient's score is 0, which is reassuring but not a free pass. Calcium score detects calcified plaque, not soft plaque, and doesn't capture inflammation. Curt emphasizes HS-CRP (high-sensitivity C-reactive protein) as a marker of systemic inflammation, which drives soft plaque formation. [0:40:22] Medications in the Case Study: Statin, Nexium, Amlodipine, Zoloft Curt walks through a specific patient on multiple meds: Atorvastatin (statin) Curt questions its necessity given: Calcium score of 0 Lipid values that don't look catastrophic Recommends advanced lipid testing and provides patients with evidence-based reasons to discuss with their provider if they want to stop. Nexium (PPI) Discusses risks of long-term proton pump inhibitor use: Impaired absorption of magnesium, calcium, micronutrients Possible cognitive, kidney, and bone issues. Insists on a taper, not cold turkey, due to rebound reflux. Amlodipine (blood pressure med) Often can be tapered fairly quickly, especially when: Lifestyle changes are implemented (diet, exercise). Magnesium intake is optimized (many people take too little magnesium). Curt's view: conventional medicine often drives blood pressure too low in older adults; some elevation is physiologically adaptive. Zoloft (SSRI) Must be tapered, like most psychiatric meds, to avoid withdrawal and symptom flare. [0:46:10] Magnesium, Omega-3s, and Simplifying the Supplement Stack Curt reviews the patient's supplement list and simplifies: Multivitamin: Advocates a high-quality multi (not basic synthetics like Centrum). Prefers one that already includes CoQ10 (e.g., 100 mg), so separate CoQ10 can be discontinued. Vitamin D: Should be taken with vitamin K to direct calcium into bone and away from arteries and organs. Omega-3s: Many people take half the necessary dose. Recommends triglyceride-form omega-3s like DHA Extra (~960 mg DHA) for inflammation and blood pressure. Magnesium: Suggests glycinate or taurate forms for better absorption and blood pressure benefits. Probiotics: Curt suggests taking breaks (e.g., a month off) and rotating brands/strains, including spore-based types. Seasonal products: The patient takes quercetin + stinging nettle for allergies. Curt recommends seasonal use only for seasonal allergies, saving money and reducing pill fatigue. For lipids and blood sugar, Curt favors BerberCol (berberine + bergamot) to: Improve numbers (to satisfy doctors). More meaningfully affect ApoB and related risk markers. Weight & energy: Patient had been using weight-loss products. Curt shifts focus to fixing sleep and overall lifestyle rather than stacking more “fat burners.” Saffron: He distinguishes between saffron extracts for mood vs. saffron for weight management—formulation details matter. [0:54:57] Closing: Funding for Alternative Health and Supplement Tax Benefits Ed shares policy/legislative updates: Alternative health funding preserved in the federal budget. Initial fear that support would be cut; instead, it was kept in the proposed budget. The Dietary Supplement Access Act proposal: Would classify dietary supplements as a qualified medical expense in the IRS code. Allow individuals to claim up to $500/year (and $250 for married filing separately) for supplements. Could apply to common products like multivitamins, vitamin D, etc. if/when finalized.  The post Radio Show / Podcast – June 14, 2026 first appeared on Vital Health Radio.

Eine standortgerechte Kalkung ist die Grundvoraussetzung für nachhaltigen und klimaresilienten Ackerbau – ökologisch wie wirtschaftlich. Nur bei optimalem pH-Wert entfalten Nährstoffe wie Stickstoff, Phosphor, Calcium und Magnesium ihre volle Wirkung und steigern die Nährstoffeffizienz. Doch was macht eine optimale Kalkdüngung aus und hat sie auch einen ökonomischen Mehrwert? Darüber spricht Moderator Dr. Bruno Görlach, Bereichsleiter Pflanzenbau und Landtechnik im DLG-Fachzentrum Landwirtschaft & Lebensmittel, mit Dr. Andreas Weber, Bayerische Düngekalk Gesellschaft, und Eric Pehle, Landwirt aus der Soester Börde und Agrarreferent an der Katholischen Landvolkshochschule Hardehausen. Die Experten erklären, worauf es bei der Kalkdüngung ankommt, wovon der Kalkbedarf abhängt und wie eine Kalkung ökonomisch zu bewerten ist. Klar wird: die Kalkdüngung ist die Basis für guten Ackerbau. Mehr Informationen: DLG-Merkblatt 456: Hinweise zur Kalkdüngung Die optimale Kalkdüngung Böden ohne Kalk sind Böden ohne Zukunft DLG-Ausschuss Pflanzenernährung Weitere Infos zur Kalkdüngung auf der Seite von Naturkalk: https://naturkalk.de/ Bodenprobenahme: Schlüssel für effizientes Nährstoffmanagement - DLG-Podcast Erfolgreicher Ackerbau - Teil 12: Hier geht's zum DLG-MediaCenter mit Podcasts aus den Bereichen Agrar & Food, Videos und vielfältigen Publikationen!

-10% sur votre 1ère commande Nutripure avec le code BIOMECANIQUE : ⁠⁠⁠⁠⁠https://nutripure.fr⁠⁠ Le Pr Philippe Humbert est dermatologue, spécialiste en médecine interne et ancien chef du service de dermatologie du CHU de Besançon. Son dernier livre Qu'est-ce qui ne va pas dans mes intestins ? - Face à l'errance médicale : comprendre pour traiter est disponible partout (lien ci-dessous).⁠Site internet⁠⁠Chaîne Youtube⁠ ⁠Facebook⁠ ⁠Instagram⁠ ⁠Livre Qu'est-ce qui ne va pas dans mes intestins ?⁠⁠Livre Les Parasites : ces hôtes invisibles qui envahissent notre corps⁠ CHAPITRES :0:00 Introduction2:25 Peau, parasites et intestin6:56 L'hyperlaxité comme terrain11:18 Comprendre l'intestin poreux15:55 Deux aliments en cause20:03 Signes chez l'enfant21:50 Détecter l'intolérance au gluten24:41 Faut-il tout éviter ?26:56 Cibler les patients en errance28:34 Le débat sur le gluten moderne31:43 L'intolérance peut-elle apparaître tard ?34:20 Calcium, lait et alternatives38:49 Le cas de la whey40:57 Réintroduire le gluten42:50 Peut-on traiter autrement ?45:52 Tensions au gluten49:13 Traiter l'entérite59:12 Quand traiter les parasites1:02:26 Signes cutanés révélateurs1:09:17 Alimentation et acné1:12:10 Le vrai impact des UV1:15:39 Pollution ou alimentation ?1:17:46 Compléments pour l'intestin1:19:41 Microbiote et fasciasBIOMÉCANIQUE :​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Discord⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠La Lettre Biomécanique⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠™⁠⁠ Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Most athletes focus on muscles.But what about the framework that supports them?In this episode of Find Your Edge, Coach Chris Newport and dietetic intern Emily Qiu discuss why bone health matters for athletes of all ages.We cover:bone mineral density and agingwhy bone density peaks around age 30DEXA scans and why they matterstress fractures and injury preventioncalcium, vitamin D, protein, and magnesiumRED-S and low energy availabilitystrength training for stronger boneswhy cyclists and swimmers should pay attentionIf you want to stay active, strong, and independent for decades to come, this episode is for you.Learn more about the Endurance Edge Longevity Lab (with ongoing metrics, nutrition and genetics for clarity in your performance and health pathway): https://www.theenduranceedge.com/longevityOr book a 30 minute quick start nutrition consult to dial in your bone health with sports nutrition, metrics and more: https://www.theenduranceedge.com/sports-nutrition-for-performance-longevity/ Support the show

Heart disease often develops silently for decades before symptoms ever appear, which is why early detection can be one of the most powerful tools for protecting long-term health and longevity.     On today's show, I break down the Coronary Artery Calcium (CAC) Score, also known as the Agatston Score, and why it may be one of the most important cardiovascular screening tools for adults over 40.     We'll explore what this scan measures, how the scoring system works, and what different score ranges may reveal about your future heart disease risk.     I'll also explain the limitations of the test, why plaque buildup can begin long before symptoms arise, and how lifestyle, inflammation, blood sugar balance, and other health markers all play a role in cardiovascular health.     Most importantly, you'll learn why prevention and early awareness matter so much, and how foundational health habits may help support long-term heart health and healthy aging.     So join me on today's Cabral Concept 3772 as we take a closer look at the CAC Score and what it may reveal about your cardiovascular health and longevity.   - - - For Everything Mentioned In Today's Show: StephenCabral.com/3772 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Es gibt Momente im Berufsleben eines Reisejournalisten, da schaut man auf den Stapel neuer Bücher, Pressemappen und wohlmeinender Branchenliteratur und spürt, wie die innere Gangway langsam hochgezogen wird… Besonders zuverlässig passiert das bei Kreuzfahrtbüchern. Denn seien wir ehrlich: Die Welt ist nicht arm an Berichten über schwimmende Ferienanlagen, an hymnischen Beschreibungen von Sonnenuntergängen über dem Lido-Deck oder an literarisch ambitionierten Schilderungen jener existenziellen Grenzerfahrung, die darin besteht, am Seetag zwischen drei Buffets und zwei Shows wählen zu müssen. Meine Begeisterung war also überschaubar, als das nächste Manuskript über die große weite Welt auf See auf meinem Schreibtisch landete. Brauchen wir wirklich noch einen Reisebericht über „Abenteuer“ auf einem 6.000-Betten-Pott? Noch eine salzige Liebeserklärung an Balkonkabinen, Captains Dinner und das große Glück, morgens in einer anderen Destination aufzuwachen, während im Hintergrund die Klimaanlage summt und die Landstrom-Frage diskret über die Reling geworfen wird? Denn leider viel, was über Kreuzfahrten publiziert wird, ist ungefähr so gehaltvoll wie Instant-Milchreis in der Crew-Messe: süßlich, klebrig und ohne nennenswerten Nährwert für den kritischen Geist… Dann allerdings sah ich den Namen auf dem Cover: Christofer Knaak. Damit war das Interesse bei mir doch geweckt. Christofer ist, wie auch Franz Neumeier von Cruisetricks, keiner jener Autoren, die Kreuzfahrt vor allem als Kulisse für Selbstbegeisterung missverstehen. Er kennt die Branche. Er konsumiert sie nicht nur aus der Perspektive des Champagnerglases, sondern betrachtet sie mit journalistischem Handwerkszeug, historischem Bewusstsein und einem Blick für jene Details, die in PR-Texten gern hinter Adjektiven wie „einzigartig“, „exklusiv“ oder „unvergesslich“ versenkt werden. Sein neues Buch „Vorm Bug die Welt“ ist deshalb keine Broschüre im Hardcoverformat, sondern eine angenehm wache, kenntnisreiche und mitunter wunderbar entromantisierende Vermessung der Seereise. Seereise statt Bettenburg mit Schornstein Knaak interessiert sich nicht für die üblichen Rennstrecken des Massenmarkts, auf denen die Branche ihre Kapazitäten durchoptimiert wie ein Logistikunternehmen mit Showbühne. Sein Blick gilt der eigentlichen Seereise: kleineren Einheiten, besonderen Routen, Schiffen mit Charakter und Situationen, in denen das Meer nicht nur Hintergrundbild für Selfies ist, sondern tatsächlich eine Rolle spielt. Drei Stationen seines Buches zeigen sehr schön, worum es ihm geht. Da ist zunächst die Antarktis, bereist auf der *Sea Explorer*. Schon die Drake-Passage, jene berüchtigte Wasserstraße zwischen Südamerika und der Antarktischen Halbinsel, liefert die dramaturgische Fallhöhe gleich mit. Bei der Anreise zeigt sie sich als beinahe zahmer „Drake Lake“, auf der Rückfahrt dann als veritabler „Drake Shake“ mit acht Meter hohen Wellen und der freundlichen Einladung an die Passagiermägen, ihre bisherige Ordnung zu überdenken. Wer danach noch Energie, Mut oder eine leicht problematische Neigung zur Selbstprüfung besitzt, springt wie Knaak bei rund einem Grad Wassertemperatur ins Südpolarmeer. Sein Fazit ist ebenso schlicht wie richtig: Dort unten steht der Pinguin über dem Homo sapiens. Eine Erkenntnis, die man einigen Produktentwicklern der Branche gelegentlich auf die Tischvorlage drucken möchte. Ganz anders, aber nicht weniger aufschlussreich, ist die Passage über den schwedischen Göta Kanal an Bord der *MS Juno*, Baujahr 1874. Hier wird Luxus radikal neu definiert. Die Kabinen messen ungefähr 1,5 mal 2 Meter – ein Format, das heutigen Suite-Kunden vermutlich als begehbarer Kleiderschrank mit historischem Charme verkauft würde. Doch genau in dieser Reduktion liegt der Reiz. Kein schwimmendes Einkaufszentrum, keine Wasserpark-Architektur, keine LED-getränkte Erlebnisüberforderung. Stattdessen: Entschleunigung, Handwerk, Nähe zum Wasser. Um den historischen Rumpf in den engen Schleusen zu schützen, nutzt die Crew keine Plastikfender, sondern Birkenstämme. Manchmal ist Nachhaltigkeit eben keine Powerpoint-Folie, sondern ein Stück Holz. Und dann ist da noch die *Sea Cloud Spirit* vor den Kanaren: 138 Meter Schiff, 28 Segel, von Hand gesetzt. Während die Passagiere mit jener Mischung aus Andacht und leichter Ungläubigkeit nach oben blicken, arbeitet die Crew in schwindelerregender Höhe. Hier wird sichtbar, was in der Kreuzfahrtindustrie zunehmend selten geworden ist: maritimes Können, das nicht vollständig durch Hotelmanagement, Yield-Optimierung und Entertainmentdramaturgie ersetzt wurde. Mit Salzgehalt gegen Seemannskitsch Schon im Vorwort, das Knaak passend „Einschiffung“ nennt, macht er klar, dass er der Romantik nicht unbewaffnet begegnet. Er nimmt sich ein beliebtes Bild vor: die angebliche Nähe des Menschen zum Meer, weil Tränen und Ozean denselben Salzgehalt hätten. Ein hübscher Satz, bestens geeignet für Kalenderblätter, Taufreden und die sentimentalen Absätze in Kreuzfahrt-Katalogen. Nur leider falsch. Meerwasser enthält im Durchschnitt etwa 3,5 Prozent Salz. Eine menschliche Träne kommt auf rund 0,9 Prozent. Die Verbindung zwischen Mensch und Meer liegt also nicht in dieser poetischen Gleichung, sondern tiefer: in den Bausteinen unseres Körpers, in Natrium, Chlorid, Kalium und Calcium. Es ist typisch für dieses Buch, dass Knaak den Zauber nicht zerstört, sondern präzisiert. Er nimmt dem Meer nicht seine Faszination. Er befreit es nur vom schlechten Marketing. Für Touristiker ist genau das interessant. Denn die Branche steht seit Jahren vor der Frage, wie viel Mythos sie braucht – und wie viel Wirklichkeit sie erträgt. Kreuzfahrt lebt von Sehnsuchtsbildern, keine Frage. Aber eine Industrie, die weiter wachsen will, kann sich nicht dauerhaft in Sonnenuntergangslyrik einrichten, während Häfen über Overtourism klagen, Umweltverbände Messwerte vorlegen und die Crew unter Bedingungen arbeitet, die im Gästebereich kaum jemand sehen möchte. Versenker: Umwelt, Overtourism, Flaggenstaaten Der eigentliche Wert von „Vorm Bug die Welt“ liegt darin, dass Knaak genau diese Schattenseiten nicht ausblendet. In Kapiteln wie „Auf grünem Kurs“ und „Crew only“ verlässt er konsequent das Sonnendeck der Behauptungen und steigt hinab in die Maschinenräume der Realität. Cruise-Fachjournalist Christofer Knaak Er schreibt über Umweltaspekte, über die komplizierte Transformation einer Branche, die gern von Zukunft spricht, aber in der Gegenwart noch reichlich schwere Altlasten mitführt. Er thematisiert Overtourism, etwa in Venedig, wo die Kreuzfahrt jahrelang als besonders sichtbares Symbol für die Überforderung fragiler Stadträume stand. Und er blickt auf die ökonomischen und juristischen Konstruktionen hinter den Kulissen: Flaggenstaaten wie Bahamas oder Malta, steuerliche Optimierungen, Arbeitsregime, Verantwortlichkeiten, die sich je nach Bedarf erstaunlich elastisch anfühlen. Dabei verfällt Knaak nicht in pauschale Verdammung. Das ist wichtig. Denn die Kreuzfahrt ist nicht nur ein Problem, sie ist auch ein Produkt mit enormer Nachfrage, hoher Wertschöpfung, großer emotionaler Bindung und beträchtlichem Innovationsdruck. Wer sie verstehen will, muss mehr können als empört winken. Knaak kann das. Er ordnet ein, statt nur zu urteilen. Auch historisch liefert er Substanz. Die Branche beginnt bei ihm nicht mit Wasserrutschen und Spezialitätenrestaurants, sondern unter anderem mit Albert Ballin und der Hapag. Die erste „Lustreise“ der *Augusta Victoria* im Jahr 1891 erscheint dabei nicht als romantischer Geistesblitz, sondern als das, was sie auch war: ein klug kalkuliertes Geschäftsmodell, um Schiffe im Winter nicht ungenutzt herumliegen zu lassen. Kreuzfahrt war von Anfang an Sehnsucht und Auslastungsmanagement. Wer heute Revenue Management betreibt, darf sich also durchaus in einer langen Tradition sehen – wenn auch nicht zwingend in einer edlen. „Passenger Area – Start Smiling!“ Besonders lesenswert ist das Kapitel „Crew only“. Es sollte Pflichtlektüre für alle sein, die glauben, das Lächeln des Stewards sei im Preis der Balkonkabine selbstverständlich enthalten. Knaak beschreibt die Grenze zwischen Gästewelt und Arbeitswelt nicht abstrakt, sondern anhand eines Schildes: „Passenger Area – Start Smiling!“ Mehr muss man über emotionale Dienstleistungsarbeit eigentlich kaum wissen. Hinter dieser Tür beginnt die Performance. Müdigkeit, Heimweh, Rückenschmerzen, schlechte Laune – alles bleibt draußen. Drinnen wartet der Gast, und der hat schließlich Urlaub. Auf der *MS Europa*, so erzählt Knaak, zählen Crewmitglieder die Zeit bis zum Abmustern nicht in Wochen, sondern in Schnitzeltagen. Jeden Sonntag gibt es Schnitzel. Ein Kalender aus Panade. Man kann darüber lächeln, sollte aber nicht übersehen, was dahintersteckt: lange Verträge, wenig Privatsphäre, harte Routinen. Ein Arbeitstag kann bis zu 14 Stunden dauern. Das See-Arbeitsübereinkommen erlaubt monatliche Arbeitszeiten, die an Land vermutlich jeden Betriebsrat in Schnappatmung versetzen würden. Während der Gast über Servicequalität urteilt, stemmt die Crew ein System, das auf perfekter Freundlichkeit bei maximaler Effizienz beruht. Dass Reedereien Teile der Vergütung über Service-Entgelte faktisch an den Kunden delegieren, ist aus Unternehmenssicht elegant. Aus moralischer Perspektive wirkt es eher wie ein Taschenspielertrick mit Bordkarte. Buch als Branchenlektüre „Vorm Bug die Welt“ ist kein Anti-Kreuzfahrt-Buch. Zum Glück. Davon gibt es ebenfalls genug, und viele sind ungefähr so differenziert wie ein Shitstorm mit Seekrankheit. Knaak schreibt aus Sympathie zur Seereise, aber nicht aus Blindheit gegenüber der Industrie. Das macht sein Buch wertvoll – gerade für Profis im Tourismus. Er zeigt, dass eine Reise auf kleineren, charaktervollen Schiffen wie der *Artania*, der *MS Europa* oder historischen und spezialisierten Einheiten etwas anderes sein kann als das standardisierte Dahingleiten auf anonymen Megalinern. Er zeigt aber auch, dass diese Differenz nicht von selbst entsteht. Sie braucht Haltung, Produktintelligenz, gute Routenplanung, faire Arbeitsbedingungen, glaubwürdige Nachhaltigkeit und Gäste, die mehr erwarten dürfen als Quadratmeter, Buffetmeter und Showminuten. Für jemanden wie mich, der die angekündigten Neubauten der kommenden Jahre eher mit hochgezogener Augenbraue als mit Champagnerlaune betrachtet, ist dieses Buch eine wohltuende Erinnerung daran, was Seefahrt sein könnte: Begegnung mit Natur, Technik, Menschen und Geschichte. Nicht bloß ein schwimmendes Konsumversprechen mit Hafenblick. Die Empfehlung lautet daher: kaufen, lesen, Verstand einschalten. Und den PR-Kitsch bitte an der Gangway abgeben. Wer mehr über die Macher, Mechanismen und Zumutungen dieser Branche hören möchte: Im Reiseradio-Podcast, den Sie mit einem kleinen Klick auf das Kopfhörer-Symbol im Titelbild abrufen können, haben wir auch Christofer Knaaks Buch analysiert (mit Hilfe der Redaktions-KI-Tools) und daraus ein munteres Gespräch produziert  – für die, die lieber nebenbei hören als nicht nebenbei zu lesen Bis dahin: immer eine Handbreit Wasser unter dem Kiel. Und gelegentlich auch eine Handbreit Skepsis im Kopf. Das Buch bei Amazon – hier klicken Um den Podcast anzuhören, bitte auf das Kopfhörer-Symbol im Titelbild klicken Der Beitrag Kreuzfahrt-Buch mit Biss Christofer Knaak blickt hinter die Bordkulissen erschien zuerst auf Was mit Reisen.

Heart disease often develops silently for decades before symptoms ever appear, which is why early detection can be one of the most powerful tools for protecting long-term health and longevity.     On today's show, I break down the Coronary Artery Calcium (CAC) Score, also known as the Agatston Score, and why it may be one of the most important cardiovascular screening tools for adults over 40.     We'll explore what this scan measures, how the scoring system works, and what different score ranges may reveal about your future heart disease risk.     I'll also explain the limitations of the test, why plaque buildup can begin long before symptoms arise, and how lifestyle, inflammation, blood sugar balance, and other health markers all play a role in cardiovascular health.     Most importantly, you'll learn why prevention and early awareness matter so much, and how foundational health habits may help support long-term heart health and healthy aging.     So join me on today's Cabral Concept 3772 as we take a closer look at the CAC Score and what it may reveal about your cardiovascular health and longevity.   - - - For Everything Mentioned In Today's Show: StephenCabral.com/3772 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Constantly dealing with tight traps, muscle tightness, jaw tension, teeth grinding, or eye twitching? Discover the connection between magnesium and calcium, why your muscles stay tight, and how to finally relieve chronic muscle tension naturally.

Daily Vlog about topics of the day. Discuss my vitamin D and Calcium blood test results and some fun physics. #running #fitness #bodybuilding #powerlifting #chat #exercise #zwift #cocodona#rucking

In this episode of The Dairy Nutrition Blackbelt Podcast, Dr. José Santos, Professor at the University of Florida, explains calcium regulation in dairy cows and how mineral-related disorders during transition affect health, intake, immunity, and lactation outcomes. Learn the differences between clinical and subclinical hypocalcemia and why recovery after calving matters. Listen now on all major platforms!"Borderline low blood calcium that persists for a few days can alter intake, attenuate innate immune response, and contribute to negative outcomes."Meet the guest: Dr. José Santos is a Professor at the Department of Animal Sciences at the University of Florida. His work focuses on dairy cow health, production, reproduction, and nutrition-health interactions, with prior experience at UC Davis and training at the University of Arizona, UC Davis, and the University of Sydney. Hear more from Dr. Santos on The Dairy Nutrition Blackbelt Podcast, available on all major platforms.Liked this one? Don't stop now — Here's what we think you'll love!What will you learn: (00:00) Highlight(02:14) Introduction(04:29) Calcium regulation(05:49) Clinical hypocalcemia(06:53) Dyscalcemia risk(08:33) Borderline calcium(09:39) Transition challenges(11:58) Closing thoughtsThe Dairy Nutrition Blackbelt Podcast is trusted and supported by the innovative companies:* Adisseo* Kemin* Vetagro* Barentz* Fortiva- DietForge- Virtus Nutrition- Esmilco Inc.

Osteoporosis may present after menopause, but prevention starts decades earlier. In this episode of BackTable Women's Health, Dr. Carla Gunn, guest host and OBGYN, interviews Dr. Pooja Luthra, an endocrinologist at UConn Health, about osteopenia, osteoporosis, and practical strategies for lifelong bone health. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction03:28 - Why Bone Health Matters Early05:23 - Bone as a Vital Sign08:02 - Amenorrhea and Early Screening09:51 - Calcium, Vitamin D, and Protein15:11 - Menopause Bone Biology Explained21:58 - Metabolic Diseases and Bone Risk25:58 - Early Screening Red Flags27:53 - Hormone Therapy Bone Benefits30:59 - Reading DEXA Scores33:42 - FRAX Scores35:09 - Modern Treatment Sequencing38:02 - Bisphosphonates Mechanism and Concerns41:16 - Secondary Labs and Referrals44:23 - Closing Thoughts --- More about this episode Dr. Luthra explains how peak bone mass is largely established by early adulthood, followed by accelerated loss during the perimenopausal/menopausal transition due to estrogen decline, inflammatory cytokines, altered calcium absorption, and increased bone resorption. She reviews prevention strategies, including adequate calcium, vitamin D, and protein intake, resistance training, and avoiding smoking and excess alcohol use. The discussion also covers high-risk conditions that can negatively impact bone health, including amenorrhea, premature ovarian insufficiency, hyperthyroidism, diabetes, and chronic kidney disease, along with considerations for earlier screening in these patients. Dr. Luthra walks through DEXA interpretation, including T-scores, Z-scores, trabecular bone score (TBS), and FRAX assessment. She closes the conversation by outlining treatment sequencing with anabolic agents before antiresorptives, bisphosphonate safety, alternative therapies, and secondary osteoporosis workup labs. --- Resources FRAX Tool:https://www.fraxplus.org/calculation-tool --- BackTable Women's Health is the go-to podcast for gynecologists, gynecologic surgeons, and other healthcare professionals focused on women's health. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

This episode explores the relationship between calcium intake and oxalate in kidney stone prevention, emphasizing the importance of dietary sources over supplements, and debunking common misconceptions about oxalate and calcium pairing.Get Featured!Leave us a voice message at call.show/kidneystonediet to be featured on the show!Chapters(00:00) - Understanding Calcium and Oxalate Interaction (12:03) - The Importance of Whole Foods Over Supplements ——When you're ready, here's how I can helpSince 1998, I've helped thousands of patients prevent kidney stones. With my Kidney Stone Diet All-Access Pass, you get access to every prevention tool I've ever created:Weekly Kidney Stone Diet Meal Plans​4 meals per day, 7 days per weekWeekly Kidney Stone Prevention Group Consultations3 video calls per week with me and the Kidney Stone Diet communityAll of my Kidney Stone Diet EbooksLow Oxalate Protein Bars, Kidney Stone Safe Smoothies, Kidney Stone Safe Snacks & Desserts, and the Low Oxalate CookbookPlus, 20% Off Private ConsultationsAnd, as a BONUS, you'll get my flagship Kidney Stone Prevention Course (normally $249) absolutely free!LEARN MORE!——WHO IS JILL HARRIS? _Since 1998, Jill Harris has been the #1 kidney stone prevention nurse helping patients prevent kidney stones. Drawing from her work with world-renowned University of Chicago nephrologist, Dr. Fred Coe, and the thousands of patients she's worked with directly, she created the Kidney Stone Diet®. With a simple, self-guided online video course, meal plans, cookbooks, group consultations, and private consultations, Kidney Stone Diet® is Jill's effort to help as many patients as possible prevent kidney stones for good.

Too much calcium fuels disease—Dr. Levy explains how magnesium and other nutrients prevent bone loss, microcalcification, and systemic inflammation. #CalciumDangers #MagnesiumPower #BoneHealth #HealthTalks

Love to hear from youOUR ELECTRICAL SELF NEEDS TO WALK WALK WALK. LOVE PIEZOELECTRICITY. YOU MAY LIKE THE FOLLOWING AUDIO LINKS  BY DR CAROLINE!TISSUE SALT: CALCAREA PHOSPHORICUM (CALC PHOS)TISSUE SALT: SILICEASupport the showCaroline S Walrad, Ph.D. is Doctor of Homeopathic Philosophy. The goal of this article is to educate others. Homeopathy doesn't treat or diagnose an illness; it addresses the entire person as a matter of wholeness that is an educational process, not a medical one. It is the reader's responsibility to inform their physician of any physical symptoms.

Today on the radio show. 1 - Smoko. Weekend of wins. 6 - Three quarter Miachael Angelo. 10 - Calcium shaming. 14 - Enhanced games update. 17 - Content stealers. 1.5x speed, Jay and Dunc. 21 - Indy 500 close win. 23 - Things that people never say. 26 - WSL Surf League. 31 - Huberman reset. 36 - Must watch. 39 - Late mail. 44 - Last drinks. Show notes https://shorturl.at/4lGjp Must watch - https://www.youtube.com/watch?v=K6xvsdLwrvY

Power plant water and steam chemistry is not a background task. It affects safety, reliability, metallurgy, production, and the decisions plant teams make under pressure. In Part 1 of this conversation, Trace Blackmore, CWT, welcomes Bradley Buecker of SAMCO Technologies and Buecker Associates to examine what happens when familiar assumptions go unchallenged. Safety Comes First in High-Energy Systems Bradley begins with the lesson that has shaped decades of his work: safety. Power and industrial systems involve heat, flow, moving equipment, chemicals, confined spaces, lockout/tagout requirements, and PPE decisions that cannot be treated casually. That safety lens carries directly into the discussion of flow accelerated corrosion, or FAC. Bradley explains how older thinking around removing all oxygen from high-pressure steam generation systems helped shape all-volatile treatment reducing programs. However, research following a catastrophic 1986 feedwater line failure showed that chemistry, flow conditions, pH, temperature, and piping geometry can combine to thin protective oxide layers on carbon steel. "Water is Water" Is a Risky Mindset Trace and Bradley then challenge one of the most expensive assumptions in industrial plants: "water is water." Bradley explains why boiler makeup treatment, softener performance, hardness control, and operating discipline deserve attention before failures appear. Low-pressure and intermediate-pressure boilers may tolerate a range of dissolved solids, but hardness remains a serious threat. Calcium and magnesium can form calcium carbonate scale in hot boiler environments, especially when softeners are poorly maintained, overrun, or bypassed to keep production moving. Bradley shares examples where short-term operating decisions led to tube failures, re-tubing, hydrogen damage, and costly downtime. Layup, Stainless Steel, and Data Before Assumptions The conversation also covers proper layup, oxygen and moisture corrosion, nitrogen capping, dehumidified air, vapor phase corrosion inhibitors, and why idle systems need a plan. Bradley reminds listeners that protecting the boiler is not enough; condensers, low-pressure turbines, and other surfaces also matter. Finally, Bradley discusses stainless steel selection and why 304L or 316L should never be treated as a universal cure for corrosion. Chlorides, deposits, cycling in cooling towers, and pitting risk all need to be evaluated before materials decisions become expensive lessons. His closed cooling water case history reinforces the same principle: do not clean, treat, or specify based on assumption. Get the data first. Good water treatment decisions protect people, equipment, and production. This conversation is a reminder that experience matters, but so does the willingness to ask questions, challenge old habits, and reach out before a problem becomes a failure. Listen to the full conversation above. Explore related episodes below. Stay engaged, keep learning, and continue scaling up your knowledge! Timestamps 02:30 — Trace opens the episode by thanking listeners for encouraging him to share more personal reflections, showing how audience feedback shapes the podcast. 04:50 — Trace highlights upcoming industry events, including ACE26 and The Water Expo, and reminds water professionals to use the Scaling UP! H2O events section for career and networking opportunities. 07:10 — James McDonald presents Words of Water, defining the mole and keeping technical learning approachable for industrial water professionals. 09:10 — Trace welcomes Bradley Buecker of SAMCO Technologies and Buecker Associates as his lab partner for the episode. 10:00 — Bradley summarizes his career across coal-fired utilities, water treatment, steam generation chemistry, air emissions control, engineering firms, and water treatment companies. 11:30 — Bradley identifies safety as the most important lesson from his career, emphasizing PPE, lockout/tagout, confined spaces, chemicals, and high-energy systems. 12:50 — Bradley challenges the phrase "that's the way we've always done it," pointing to changes in membrane technologies, high-pressure steam chemistry, and cooling water treatment. 13:50 — Bradley introduces two major concerns: flow accelerated corrosion and the dangerous assumption that "water is water." 15:10 — Bradley explains the historical focus on removing oxygen from high-pressure steam systems using mechanical deaerators and reducing agents. 16:10 — Bradley describes the 1986 nuclear plant feedwater line failure that killed four personnel and intensified research into FAC. 18:50 — Bradley explains how AVTR chemistry, flow conditions, fittings, pH, and temperature can thin protective oxide layers and lead to catastrophic failure. 20:20 — Bradley discusses how high-purity feedwater with a small amount of dissolved oxygen can form a denser oxide layer that protects carbon steel from FAC. 23:50 — Bradley compares oxygen scavengers, including sulfite, hydrazine, carbohydrazide, DHA, and methyl ethyl ketoxime, and explains where their use differs. 26:50 — Trace and Bradley unpack why "water is water" often means water is treated as the last priority instead of the first. 28:10 — Bradley explains why sodium softening, hardness control, and boiler makeup treatment are essential for low- and intermediate-pressure boilers. 31:00 — Bradley shares examples of softener bypass decisions that can lead to boiler damage, tube failures, re-tubing, and costly downtime. 36:50 — Bradley explains why layup matters, especially when water cools, air enters, and localized corrosion develops inside idle equipment. 42:00 — Bradley warns that stainless steel is not a cure-all and explains how chloride concentration and pitting risk affect 304L and 316L applications. 45:50 — Bradley shares a closed cooling water case history where black material was assumed to be iron but turned out to be bitumen from an unsuitable pipe liner. 51:00 — Bradley stresses the need for data before action, explaining how an incorrect cleaning assumption could have compounded a seven-figure materials mistake. 52:50 — Trace and Bradley discuss the value of experience and why younger professionals should seek training, conferences, vendors, and technical networks. 54:20 — Bradley speaks to the importance of mentorship as experienced professionals retire and critical industry knowledge risks being lost. 59:40 — Trace closes Part 1 and previews Part 2, which will continue the conversation on oxygen scavengers, pretreatment stories, and Bradley's career. Connect with Bradley Buecker Email: bueckerb@samcotech.com   LinkedIn: https://www.linkedin.com/in/bradley-buecker-705b9021/     Guest Resources Mentioned   ASME CRTD 34 / ASME Consensus document Barry Dooley – "Flow-Accelerated Corrosion in Fossil and Combined Cycle/HRSG Plants" IAPWS Technical Guidance Document – Volatile Treatments   Brad Buecker's HRSG issues: Reemphasizing the importance of flow-accelerated corrosion control – Part 1  Industrial water and steam treatment will be important for a long time Part 1    The importance of industrial water and steam treatment, Part 2  The importance of industrial water and steam treatment, Part 3 The importance of industrial water and steam treatment, Part 4  The importance of industrial water and steam treatment, Part 4.5 The importance of industrial water and steam treatment, Part 5  The importance of industrial water and steam treatment, Part 6  The importance of industrial water and steam treatment, Part 7 Surry Unit 2 feedwater line rupture documentation   Scaling UP! H2O Resources Mentioned  AWT (Association of Water Technologies)  Scaling UP! H2O Academy video courses  Submit a Show Idea  The Rising Tide Mastermind   Words of Water with James McDonald Today's definition is the standard SI unit for the amount of substance, defined exactly as 6.02214076 x 10^23 elementary entities, such as atoms or molecules.  Can you guess the word or phrase?    2026 Events for Water Professionals  Check out our Scaling UP! H2O Events Calendar where we've listed every event Water Treaters should be aware of by clicking HERE. 

Could your DEXA scan be missing important clues about your real fracture risk? I brought Dr. Doug Lucas back because I've been getting so many questions about bone health, and I wanted to cut through the fear, myths, and confusion around osteoporosis. Dr. Doug is an orthopedic surgeon turned bone health expert, and in this conversation, we talk about why bone loss is not something you just have to accept with age. We dig into the food, exercise, testing, hormones, and daily habits that can help you build stronger bones and reduce fracture risk. What you'll learn: (03:39) Calcium alone is not the full answer for preventing fractures and may come with risks when taken without vitamin D. (04:29) Walking can help slow bone loss but is not enough to reverse osteoporosis. (06:48) A normal DEXA scan does not automatically mean your fracture risk is low. (09:34) Osteoporosis medications can be useful in some cases but should not be treated as the only solution. (11:35) How Dr. Doug thinks about reversing osteoporosis by addressing the root causes of bone loss. (15:42) Which factors can drive bone loss, including hormones, medications, diet, sedentary living, and endurance training. (19:15) Starting protein earlier in the day can make it easier to hit your goals and support muscle protein synthesis. (36:08) How CTX and P1NP blood tests can help show whether you are breaking down or building bone. Love the podcast? Here's what to do: Subscribe to the podcast. Leave a review. Text a screenshot to me at 813-565-2627 and wait for a personal reply because your voice is so important to me. Full show notes (including all links mentioned): https://jjvirgin.com/drdoug If your routine or eating habits have changed recently head to BodyBio.com/JJVIRGIN to start supporting your gut. Mitopure supports the cellular energy that allows your muscles to actually respond and adapt. Mitopure gummies make it simple. Visit https://timeline.com/jjvirgin for 20% off your order. Learn more about your ad choices. Visit megaphone.fm/adchoices

Osteoporosis is often called a silent disease because many people do not know they have it until they suffer a fracture. But when should you start paying attention to your bone health — and what can you do now to protect yourself?In this episode of Baptist Health Talk, host Johanna Gomez speaks with Dr. Maria Kyriacou, primary care sports medicine physician with Baptist Health Orthopedic Care, about osteoporosis, bone density, menopause, weight loss medications, strength training and prevention.In this episode, you'll learn: What osteoporosis is and why it matters  Why bone loss can begin earlier than many people think  How menopause affects bone density  What a DEXA scan measures  Why strength training is key for stronger bones  How nutrition, calcium, vitamin D and protein support bone health  Whether Pilates, yoga and weightlifting are safe  How weight loss medications may affect nutrition and bone density  Why men also need to pay attention to osteoporosis  How AI may help patients access better resources and information If this conversation was helpful, subscribe for more trusted health guidance from Baptist Health experts.Host:Johanna GomezAward-Winning Host & JournalistGuest:Maria Kyriacou, M.D.Primary Care Sports Medicine PhysicianBaptist Health Orthopedic Care

In this episode, Dr. Doug Lucas breaks down the latest thinking on calcium supplements for bone health, including the fear around calcium and heart attack risk. He explains why most people don't need 1,200 mg of calcium from supplements alone and why food intake should come first. He also compares calcium carbonate, calcium citrate, algae-based calcium, and bone-based calcium through the lens of absorption, safety, and fracture risk reduction.Study Linkshttps://pubmed.ncbi.nlm.nih.gov/20671013/https://pubmed.ncbi.nlm.nih.gov/31747785/Shop & Save 10% on NBI Products: https://shop.nbihealth.com/pages/dr-doug-bone-health?bg_ref=YMKzZt4KwCThis is an affiliate link, which means I may earn a commission if you purchase through it, at no additional cost to you.2024 Calcium Video:https://youtu.be/3fcbh2TVS5Y

Chronic stress and unhealthy relationships alter your minerals, slow your metabolism, and block your ability to detox. In this episode, I'm chatting with Susan Cachay about the surprising ways emotional trauma shows up on a hair tissue mineral analysis and why so many people stay stuck in burnout and poor detoxification despite doing "all the right things." Susan explains how patterns like calcium shell, sympathetic dominance, and poor eliminator patterns develop as survival adaptations. We talk about why low sodium and potassium reflect adrenal burnout, and how mineral deficiencies make it easier for toxic metals to accumulate in the body.  We also unpack the connection between emotional safety, nervous system regulation, and mineral balance, along with why minerals are one of the most overlooked foundations of longevity and healing. If your detox isn't working or your minerals have stayed stubbornly low, this conversation is for you!   "Our emotions will affect our capacity to detoxify, no matter what we're doing." ~ Susan Cachay   In This Episode: - The biochemical impact of emotional trauma on HTMA and detox - Poor eliminator metal patterns and misconceptions - Calcium shell and bioavailable calcium - Adrenal burnout and mineral imbalance - Toxic metals replacing minerals in the body - How different minerals affect emotional resilience - Healing emotional trauma stored in the body - Interpreting mineral patterns on HTMA results   Products & Resources Mentioned: HTMA Success Practitioner Training Program: Learn more at https://htmasuccess.com/  Bon Charge Red Light Face Mask: Get 15% off sitewide at https://boncharge.com with code WENDY, Tru Energy Skincare Bio Adaptive Hydration Oil: Try the oil and save up to $197 at trytruenergy.com/wendy5  Organifi Collagen: Save 20% with code MYERSDETOX at https://organifi.com/myersdetox  Fresh-Pressed Olive Oil: Try a full-size $39 bottle for just $1 to cover shipping at https://getfreshwendy.com  Heavy Metals Quiz: Check your toxicity score and receive a free video series on how to detox your body at https://heavymetalsquiz.com    About Susan Cachay: Susan Cachay, founder of the HTMA Success Practitioner Training Program, is a certified nutritionist with a Bachelor's degree in Education and a Master's in Psychology Counseling. She is one of the most trusted and experienced voices in Hair Tissue Mineral Analysis (HTMA) and Mineral-Nutritional Balancing. With over 25 years in practice, 15+ years mentoring wellness professionals, and a personal health journey that fuels her passion, Susan brings the science, the lived experience, and the heart to help clients reclaim their health and to guide practitioners in creating meaningful, sustainable careers. You can learn more about Susan's work at https://htmasuccess.com/    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Episode Highlights With KatieWhy magnesium is the master mineral your body burns through fastestThe real reason magnesium powers 700+ reactions in the bodyHow magnesium activates ATP and mitochondrial energyWhy stress, pregnancy, and modern life create chronic depletionThe difference between forms like glycinate, citrate, malate, threonate, taurate, etc.Why I personally use Magnesium Breakthrough (7 forms)How topical magnesium oils, lotions, and baths work & when to use themSymptoms of magnesium deficiency (that don't look like deficiency!)How magnesium interacts with sodium, potassium, calcium, and hormonesHow magnesium supports sleep, digestion, blood sugar & nervous system calmWhy magnesium is a primary safety signal for the bodyResources MentionedMagnesium Breakthrough supplement (use code wellnessmama for 15% off)Magnesium lotionMagnesium oilHiyaHiya created a super powered chewable vitamin for kids that packs twelve organic fruits and vegetables plus fifteen essential vitamins and minerals into every dose. Try it at hiyahealth.com/wellnessmama for 50% off your first order.BioptimizersI love and use so many products from them, but I especially love the magnesium and digestive enzymes. Visit bioptimizers.com/wellnessmama and use wellnessmama15 at checkout to get the best deal

On this episode of the Feeding Fumbles & Fixes series of Beyond the Barn, host Katy Starr chats with Dr. Kelly Vineyard, PhD equine nutritionist to discuss one of the most overlooked (and misunderstood) tools in your barn – your horse's feed tag, including: How to interpret feed tag numbers without being misled Why feeding directions are more than just a guideline The limitations of feed tags and what to look at beyond the label Whether you're feeding a performance horse, a senior or your light trail horse, this episode will help you look beyond the label and better understand how to build a balanced and effective feeding program.

Dr. Levy explains how commonly praised nutrients can become toxic, drive oxidative stress, and even increase cancer risk when consumed in excess. #ToxicNutrients #CancerRisk #OxidativeStress #HealthTalks

In this sponsored episode from Novartis Pharmaceuticals Corporation, a leading preventive cardiologist walks through the 2026 cholesterol guideline update and what it means in practice. Seth J. Baum, a Columbia-trained preventive cardiologist, founder of Flourish Research, chairman of the Family Heart Foundation, and past president of the American Society of Preventive Cardiology, breaks down the major changes in the March 2026 ACC and AHA guideline release. You will hear why LDL targets are explicit again after nearly a decade, why universal lipoprotein A screening is now recommended, why a coronary calcium score above 300 places a patient in the highest-risk treatment tier, and why apolipoprotein B measurement can refine risk assessment when LDL is at goal. Baum also covers the alternatives available when a patient cannot tolerate a statin, including ezetimibe, PCSK9 inhibitors, inclisiran, and bempedoic acid, along with practical framing for the statin-hesitant patient. You will also hear his approach to discussing cholesterol with patients, from the science of lipoprotein physiology to the case for earlier and more aggressive lipid-lowering treatment. Dr. Baum was not compensated for his participation in today's episode. The opinions expressed are his alone and do not represent the opinions of Novartis Pharmaceuticals Corporation. At Novartis, our mission is to ensure no heart is lost too soon. We envision a world where preventable CV deaths are no longer part of our lives. We're proud of the positive impact we've made over the past 40 years and remain dedicated to tackling the most challenging problems in CVD. Through cutting-edge science and technology, we are focusing on areas of high unmet need, including scaling our xRNA platform across multiple risk factors and pioneering breakthroughs for genetically driven CVD risk factors and common heart conditions, including atrial fibrillation. We also work with patients, healthcare professionals, and organizations around the world to improve CV care beyond medicine alone. Together, we can help people with CVD enjoy longer, healthier lives and more time with their loved ones. Learn more here: https://Novartis.us/cardiovascular-disease VISIT SPONSOR → https://Novartis.us/cardiovascular-disease SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this episode, I'm joined by Lindsey Lester, a British Menopause Society-accredited specialist and breast cancer survivor, for an essential conversation on bone health after cancer and menopause.Bone health is one of the most common — and least talked about — long-term effects of cancer treatment. Whether your menopause was triggered suddenly by treatment or has developed over time, the impact on your bones can be significant.We explore how treatments such as chemotherapy, endocrine therapies (including tamoxifen and aromatase inhibitors), steroids, and treatment-induced menopause can all affect bone density — across different types of cancer, not just breast cancer.We also talk about who may be most at risk, how quickly bone density can change, and why bone loss is often called a “silent” condition — with many people not realising until much later.A key part of this conversation is understanding DEXA scans — when to have one, how often to monitor your bone health, and what it really means if you're told you have osteopenia or osteoporosis.But most importantly, this episode is about what you can do.From nutrition and movement to medications and monitoring, Lindsey shares clear, practical ways to protect your bones — and answers one of the biggest questions so many people have after cancer:Can we improve our bone health without HRT?This episode will help you feel more informed, more in control, and better equipped to make decisions about your long-term health.Episode Highlights:00:00 Intro06:09 Participant introductions and background questions09:00 Discussing osteoporosis awareness plan13:03 Postmenopausal bone health risks15:16 Discussing bone health awareness20:08 Young people unaware of health risks22:49 Discussing tamoxifen and ovarian function28:51 Experiencing medical and surgical menopause31:37 Calcium and vitamin D for bone health39:52 Tracking calcium on a vegan diet44:54 Discussing exercise for bone health49:30 Cholesterol management with exercise51:47 Benefits of building muscleHere are some links we mentioned:https://theros.org.uk/information-and-support/bone-health/nutrition-for-bones/calcium/calcium-rich-food-chooser/https://strwebstgmedia.blob.core.windows.net/media/0lhowmrk/about-exercise-fact-sheet-february-2019.pdfYou can find Lindsey here: https://healthinmenopause.co.uk/meet-the-team/Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

How do you turn your patients' calcium scores into clear, personalized prevention plans? Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-two-cracking-code-coronary-artery-calcium-cac-2026a1000clt?ecd=bdc_podcast_libsyn_mscpedu

Don't skip homocysteine when testing for dementia risk factors; Treating osteoporosis; New hope against pancreatic cancer; Eating right for Parkinson's Disease; Olive oil helps stave off dementia—but only the right kind; A lifestyle hack that can cut Alzheimer's risk by 38%; How to reduce high calprotectin on a stool test.

Calcium Score to Evaluate Arterial Plaque; 50% of Statin Candidates May Not Need Them; Cholesterol Skepticism and Misunderstood Risk; Inflammation as a Key Risk Driver; Combining CRP and LDL for Better Risk Prediction; Why ApoB and Lipoprotein(a) Matter More Than LDL; Patient Case: High Lipoprotein(a) Despite Normal Cholesterol; Understanding Supplements: Red Yeast Rice and Berberine; Niacin: The Disappointing Heart Health Supplement; Amla (Indian Gooseberry) and Simvastatin Comparison; Health = Resilience ÷ Stress; Genetic Variability in Cholesterol Absorption from Food #HeartHealth #Cholesterol #LifestyleMedicine #HealthTalks

This week the hosts of In a Nutshell ask an important question. Can you get enough calcium on a plant-based diet without fortified foods? And even if you can, do you have to have a degree in nutrition to do the planning? Daisy and Clare provide a lively listen helping us to understand the role of calcium in the diet, and how to make sure you have a good intake as a plant-based eater without obsessing about which green vegetable comes with the mushroom pie.If you'd like to support our work and be part of a growing community of like-minded people working towards creating a healthier and more sustainable future please join the Plant-Based Health Professionals UK following the link below:https://plantbasedhealthprofessionals.com/membershipYou don't have to be a health care professional to join, but by doing so you're not only supporting our work, you'll be improving your own health;  with membership starting from as little as £15 a year, join us now and be part of the change you want to see.References:https://plantbasedhealthprofessionals.com/getting-calcium-on-a-plant-based-diet-everything-you-need-to-knowNourish: The Definitive Plant-Based Nutrition Guide for FamiliesReshma Shah (author), Brenda Davis (author), David L. Katz (foreword)Tong TYN, Appleby PN, Armstrong MEG, Fensom GK, Knuppel A, Papier K, Perez-Cornago A, Travis RC, Key TJ. Vegetarian and vegan diets and risks of total and site-specific fractures: results from the prospective EPIC-Oxford study. BMC Med. 2020 Nov 23;18(1):353. doi: 10.1186/s12916-020-01815-3. PMID: 33222682; PMCID: PMC7682057.Dunneram, Y., Lee, J.Y., Watling, C.Z. et al. Vegetarian diets and cancer risk: pooled analysis of 1.8 million women and men in nine prospective studies on three continents. Br J Cancer 134, 1218–1229 (2026). https://doi.org/10.1038/s41416-025-03327-4

In this video we review our top 10 tips for colon cancer prevention. Make sure to check out the full blog too - we include our RAINBOW® tips for applying all of this to IBD and the challenges we face. Top 10 Tips for Prevention:1. Colonoscopies2. Diet Pattern3. Fiber (with modifications for IBD challenges!)4. Cruciferous vegetables (adjustments available for this as needed)5. Reduced Red/Processed Meats6. Reduced Alcohol7. Calcium (adequate levels)8. Adequate Folate (with dietary sources) 9. Good Vitamin D levels10. Exercise (not too much, not too little)Be sure to check out the blog for a full explanation & more details. Plus we include modifications specific for IBD.BLOG ⬇️https://crohnsandcolitisdietitians.com/colon-cancer-prevention/

Dr. Merritt Tuttle is both a Pediatric Intensivist and Medical Toxicologist at Brenner Children's Hospital in North Carolina associated with Atrium Health and Wake Forest Baptist Health. She completed her Pediatric Critical Care and Medical Toxicology training at the Medical College of Wisconsin.Learning Objective: By the end of this podcast, listeners should be able to discuss an evidence based and expert guided approach to the evaluation and management of the critically ill child with calcium channel blocker toxicity.References:St-Onge M, Anseeuw K, Cantrell FL et al, Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Crit Care Med. 2017 Mar;45(3):e306-e315.2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareLevine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center. Ann Emerg Med. 2013 Sep;62(3):252-8. doi: 10.1016/j.annemergmed.2013.03.018. Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018 Oct;36(10):1817-1824. doi: 10.1016/j.ajem.2018.02.004. Epub 2018 Feb 6.Slamowitz A, Sweberg T, Labgold K, Nickerson T. Extracorporeal Membrane Oxygenation for Calcium Channel Blocker Intoxication: A Multicenter Retrospective Registry Review. ASAIO J. 2025 Oct 31. Poison Control: (800) 222-1222Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com.  You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!

JEMS Development Editor Mike Brown sits down with Dr. Stacy Shackelford, a coauthor of a new JAMA Network Open paper, to unpack findings about calcium abnormalities in trauma patients. The authors tracked a cohort of 1,270 trauma patients arriving at three level I trauma centers and found that 22% presented with hypocalcemia and 5% with hypercalcemia. Early mortality varied significantly by calcium status: 11.9% among hypocalcemic patients, 4.3% among eucalcemic patients, and 22.8% among hypercalcemic patients. Although hypercalcemia was less common than hypocalcemia, it was associated with substantially worse early mortality, suggesting the need for further research into the underlying mechanisms.

A deep dive into the research and nuance behind calcium supplements for people with kidney stones. Blog: Calcium Source for Kidney Stones Bargagli M, Ferraro PM, Vittori M, Lombardi G, Gambaro G, Somani B. Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review. Nutrients. 2021;13(12).   Submit a question for Melanie to answer on the podcast! Connect with The Kidney Dietitian! Work with Us! |  Instagram | Facebook | Pinterest | Facebook Group | Newsletter www.thekidneydietitian.org FREE Webinar: The 3-Step Method to Prevent Kidney Stones All information in this podcast is meant for educational purposes only and should not be used in place of advice from a medical professional.

Timestamps00:04 - Discussion about weather and summer in a light-hearted manner.02:08 - Conversations filled with humor and global greetings.06:16 - Discussion about British comedy and 'Only Fools and Horses'.08:19 - Discussion about Ken Campbell's performances and talent.12:07 - Discussion on various comedy shows and their impact.14:13 - Discussion on cholesterol levels and dietary impact.18:30 - Discussion on the unreliability of cholesterol measurement methods.20:19 - Discussion of humorous moments from British TV shows.24:15 - Understanding calcium testing and fat loss strategies.26:12 - Understanding blood tests requires nuanced interpretation beyond just numbers.29:57 - Understanding different types of hunger and their influences on eating behavior.31:52 - Food habits are influenced by upbringing and situational cues.35:49 - Parasite symptoms often overlap with common health issues.37:58 - B12 and folate are crucial for methylation and DNA synthesis.41:41 - Consult your doctor before adjusting diabetes or cholesterol medications.43:40 - Patients have the legal right to refuse medication.47:37 - Hydration should be balanced; drink to thirst instead of forcing water intake.49:31 - Moderation in drinking improves sleep quality and dietary experiments with bluegills are discussed.53:12 - Balancing dietary choices with social and family considerations is important.54:58 - Calcium sources and absorption are crucial for health.

Most women don't realize their bones have been changing long before anyone thinks to look.While hormones, metabolism, and muscle are all affected by midlife shifts, bone is already responding to stress, nutrition, and estrogen in real time. What we've been told about bone loss starting "later" isn't just incomplete. It delays the very actions that could change the trajectory.I'm joined by Dr. Ben Weitz, a functional medicine practitioner and sports chiropractor who rebuilt his own bone after a traumatic fracture using advanced nutrition, testing, and anabolic strategies. His clinical depth and personal experience make this one worth your time.If you've ever thought bone health was something to worry about later, this will change that. Listen now.Episode Timeline: 00:00 – Episode Preview00:27 – Episode Introduction02:32 – Guest Injury Story06:45 – Bone Healing Protocol10:00 – Calcium and Vitamin K13:03 – Bone Drugs Explained18:04 – Rehab and Recovery20:20 – Bone Healing Success22:17 – Key Bone Lab Tests24:05 – DEXA Scan Explained27:06 – When to Start Testing27:34 – Best Bone Exercises30:53 – Bone Building Myth33:11 – Ballistic Training Explained34:33 – Maintenance Strategy Basics37:15 – Vitamin D Importance39:23 – Minerals for Bone Health42:02 – When to Retest42:55 – Prevention Over Treatment44:27 – Final TakeawaysConnect with Dr. Ben Weitz:Clinic Phone Number: 310-395-3111Website https://drweitz.com/Rational Wellness Podcasthttps://podcasts.apple.com/us/podcast/rational-wellness-podcast/id1191232372SocialsFacebook https://www.facebook.com/ben.weitz.12/ Instagram https://www.instagram.com/drbenweitz/ YouTube https://www.youtube.com/@weitzchiroLinkedIn https://www.linkedin.com/in/weitzchiro/

Deb (00:03.606)Within the next seven months, up to 1.5 million Americans could lose access to a medication that they’ve relied on for decades. Not because it’s dangerous, but because a pharmaceutical giant may have lobbied the FDA to eliminate their competition. And if you’re one of them, your doctor may already have told you about this issue and stopped prescribing it.This isn’t a conspiracy theory. This is documented in federal court filings. This is happening right now. And the company that stands to profit, well, they’re the same ones manufacturing the only product that might survive.Today on Let’s Talk Wellness Now, we’re exposing the desiccated thyroid extract crisis, the corporate manipulation behind it, and what you need to do right now to protect your health. Stay with me because I’m about to share what could save your access to the medication keeping you alive.Welcome back to Let’s Talk Wellness Now, the show where we uncover the root causes of chronic illness, expose regulatory capture in healthcare, and empower you with the tools to advocate for yourself. I’m Dr. Deb, naturopathic doctor, your medical detective, and today we’re diving into one of the most consequential and corrupt healthcare decisions affecting patients right now. If you or someone you love takes Armour thyroid, NP thyroid, or any desiccated thyroid extract,for hypothyroidism or if you’ve struggled to find a thyroid medication that actually works for your body, this episode is absolutely critical. And if you have celiac disease, gluten sensitivity or corn allergies, what I’m about to reveal will make your blood boil. Now grab your cup of coffee, don’t forget your notebook and settle in because what’s happening to this medication right now is a masterclass in how pharmaceutical companies use regular Deb (02:06.544)agencies to eliminate competition, control markets, and price gouge patients. And I have all the receipts. Deb (02:20.982)Let me start with what might surprise you. Desiccated thyroid extract, or DTE as we call it, is actually one of the most oldest thyroid medications in the world. And I mean old. From the 1890s through 1970, this was the standard treatment for hypothyroidism.Now let’s really dive into that. From the 1890s to the 1970s, this was standard hypothyroidism treatment.In 1965 alone, and this is documented in peer-reviewed literature published in the Journal of Clinical Endocrinology and Metabolism, approximately four out of every five prescriptions for thyroid hormone in the United States were of natural desiccated thyroid preparations.The Journal of Clinical Endocrinology and Metabolism is a very high-end journal. Now think about that. This wasn’t some fringe therapy. This was mainstream medicine. Armour Thyroid, the most recognizable brand name, has been manufactured since the early 1900s, well over a century ago.and this is cited again in NIH bookshelf. When the FDA was officially established in 1938, Arbor thyroid was already on the market. And this is important and I want you to understand why. Under the federal Food, Drug and Cosmetic Act, any drug that was already being marketed before 1938 was automatically grandfathered into the system. That means it didn’t have to Deb (04:08.112)go through the formal FDA approval process. And this again is cited under the Federal Food, Drug and Cosmetic Act, grandfathered drugs and exemptions. And this is crucial to understanding what happens next. By the 1970s, synthetic levothyroxine, brand name Synthroid and generics became the preferred treatment. Hmm, wonder why?It was easier to standardize, came into consistent doses, and worked well for most patients, and could be mass manufactured. By the 1980s, levothyroxine had largely replaced desiccated thyroid in clinical practice, according to the American Thyroid Association 2014 guidelines for the treatment of hypothyroidism. But here’s what matters. Some patients…a very significant minority of them, never felt right on levothyroxine alone. Despite their lab work looking normal, they still had fatigue, brain fog, weight gain, cold intolerance, and depression.These patients often found relief when they switched back to their desiccated thyroid, which contains both T4 and T3 hormones, the way human thyroid naturally produces them. And this is not anecdotal. This is documented in randomized double-blind crossover studies published in Endocrine Practice.For decades, that was fine. Their doctors prescribed it, insurance sometimes covered it, patients were getting better, and the system worked really well. Until August 6th of 2025, just a short time ago, everything changed. On that date, the FDA sent letters to manufacturers, importers, and distributors of desiccated thyroid extract products stating that these medications would need an approval. Deb (06:04.654)a biologics licensed application, a BLA, to remain legally on the market. And this is cited in the FDA’s official statement, FDA’s actions to address unapproved thyroid medications. understand it says unapproved thyroid medications. However, desiccated thyroid, specifically Armour, has been approved since 1938. And this was dated August 6th through 7th, 2025.This wasn’t a guideline. This wasn’t a suggestion. It was an endorsement of action. And the timeline they gave them? Well, just 12 months to transition patients to another medication before enforcement action could begin.This was also cited by an FDA notice to the industry, animal derived thyroid products notice to industry, August 6th, 2025. Now do the math, that means August 2026, seven months from now, 1.5 million Americans currently taking this medication. And this number comes from the FDA official statement, citing that it’s an estimation of 1.5 million patients receiving prescriptions for these medications.could potentially lose their thyroid access. Now, here’s where it gets interesting. The FDA didn’t wake up in August of 2025 and decide to regulate desiccated thyroid after a century. This decision has a much longer backstory. And understanding that backstory is critical to understanding what’s really happening in this industry.The shift started in 2022. Back in September of 2022, over three years ago, an FDA branch chief sent a letter to the National Associations of Boards of Pharmacy noting that the agency had decided to designate DTE as a biological product, which would affect its eligibility for compounding. Deb (08:13.972)This also is cited in an FDA letter to the National Association of Boards of Pharmacy September 2022.Then two months later, in November of 2022, the FDA’s Office of Compounding Quality and Compliance sent a softer letter acknowledging that many Americans take medication to treat hypothyroidism and some choose to take DTE products. The letter stated that the FDA would focus enforcement on cases that pose the greatest public health risks, such as serious adverse offense or serious product quality or adulteration.also is cited by an FDA letter from Francis G. Bromel, the director, Office of Compounding Quality and Compliance, November of 2022. Now, let me just think about this for a second. If this drug has been on the market since the 1800s, been FDA approved since 1938, would we not have seen a health crisis long before 2022?I honestly don’t know of any other drug that’s been around this long that’s used by this many people. Now granted, I haven’t done the research on it either, which I can do for you guys, but I’m just thinking if a drug is on the market today and it causes harm, it doesn’t make it three years, five years before you see lawsuits everywhere. Why are there no lawsuits on this drug? Why are there no major reactions that people are seen having?Hmm, just thought. But here’s the pattern. The FDA was already laying the groundwork back in 2022, testing the waters, signaling where this was headed. The August 2025 action. Then this came down. Deb (10:09.806)August 6, 2025, the FDA announced its position publicly and sent formal letters to all DTE manufacturers, importers, and distributors. This was cited by the FDA Enforcement Action August 6, 2025, letters to manufacturers, importers, distributions of DTE products. The agency stated several concerns. First, DTE products have experienced quality and dosing issues.The FDA cited, and I’m quoting directly from their statement, over 500 adverse events reported associated with DTE products from 1968 to 2025. From 1968 to 2025, we had 500 adverse reactions? What is that math equate to?A couple a year? Come on guys, this is insane! With a substantial increase, you, between 2019 and 2020 that the agency suggested was related to voluntary recalls of sub-potent or super-potent products.This was cited in the FDA statement, over 500 adverse events reported associated with ADT products from 1968 through 2025.Second, the agency expressed concern about batch inconsistency. According to the FDA’s official statements, tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Okay, this was cited in the FDA statement, tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Thirdly, and I want to actually let’s back up. I want you to remember I said that Deb (12:11.216)because further down in this podcast, we’re going to talk about this. This is an important point to remember. Thirdly, the agency raised concerns about potential impurities from animal source material, including potential for viral contamination due to the animal source and supraphysiological levels of T3.the FDA statement on impurities, viral contamination and super physiological T3 levels. Now I will tell you, I’ve been prescribing armarithograde for 20 years. I’ve rarely seen a super physiological dose given of T3 in lab results, unless the patient takes their medication like four or five hours before you do the blood test, then you’ll see a false rise because you’re actually seeing the medication. You’re not seeing people walking aroundsuperphysiological T3 levels. Nobody would like that feeling. So anyway, I digress. Now let me pause here because this is where I need to give you some context that the FDA hasn’t quite emphasized yet. Of course, we have another connection and it is the China connection.So the FDA’s concerns about contaminated drugs and quality issues don’t exist in a vacuum. In 2024, the U.S. over 828,000 metric tons of pharmaceuticals, seven times the level from 2000. And here’s the kicker. China and India supply the majority of active pharmaceutical ingredients. APIs for U.S. generics accounting for 70 to 80 % of the total genericdrug supply. According to Reuters industry report in 2024, they state that China supplies 82 % of the APIs for critical drugs. Deb (14:08.204)Got to question that, right? Why are we giving all of our drug formulas to China and allowing them to import them into our country? In fact, roughly 20 % of the critical drugs have APIs exclusively sourced from China. And China controls 80 to 90 % of the global production for antibiotics and other key compounds. This was also cited by Reuters industry data thatcontrols 80 to 90 percent of the global production for antibiotics and other key compounds. Now just think about this. They control 80 to 90 percent of our medication. They control 20 percent of our critical drugs and we just put what kind of tariff on them? Hmm.In 2025 alone, the FDA issued multiple warning letters to foreign manufacturers for contamination issues and failure to follow good manufacturing practices. This is also cited by the FDA warning letters 2024 through 2025 and multiple citations to foreign manufacturing facilities. This is a systematic problem affecting the entire US drug supply, not just desiccated thyroid.So when the FDA suddenly became concerned about DTE quality and contamination, part of that concern was legitimate. But this is crucial. The same inconsistencies and contamination issues exist across the entire generic drug supply. And the FDA has not taken the same enforcement action against them. Let that sink in.They have not taken the same enforcement action against the other drug companies. So what’s behind all of this? Where is this all coming from? Hmm. Let’s address something directly, because you deserve to know it. And I’m going to cite my sources precisely so that when the medical boards have something to say about this, and they might, I have a documentation for every single word that I am about to speak. Deb (16:24.878)According to the court documents filed in October 2025, in the case ofa urine, a urine. I’m going to say that wrong. Pharmaceuticals versus Dr. George Tidmarsh from ABBV, the multinational pharmaceutical company that manufactures armor thyroid, reportedly petitioned the FDA in 2024, asking the agency to reclassify DTE as a biologic and to prohibit other manufacturers from selling unlicensed DTE products unless they havehad an investigational new drug application, we call this an IND, and a clinical development program aimed at eventual approval. This is cited in the court filing a Urena pharmaceuticals lawsuit versus Dr. George Tidmarsh, October 2025, reported by Fierce Pharma. Now let me explain why this matters and why this is one of the most brazen examples of regulatory capture I’ve ever seen in my career.AbbeVee is one of the world’s largest pharmaceutical companies. In 2024, they reported over $54 billion in revenue. Drop the mic on that one.They have the resources, the regulatory expertise, the legal teams, and the financial capacity to navigate a biologics license application process that costs between $500 million and $1 billion. Let that sink in. Deb (18:07.882)A drug that’s been on the market since the 1800s that was grandfathered in 1938 that’s making plenty of money right now. They’re going to spend 500 million to $1 billion to get a biologics license application. Why would they do that? Well, we’re about to find out. Most otherDTE manufacturers, smaller companies like Acela Pharmaceuticals, which makes NP-thyroid, and RLC Labs, which made WP-thyroid, do not have those same resources. And this is cited in Pharma Voice in 2025. Why a treatment older than the FDA is getting new regulatory scrutiny. So when you petition the FDA to reclassify a drug in a way that requires this type of expensivetime-consuming biological approval, you’re not just asking for safety. You’re asking to eliminate your competitors from the marketplace. Now, I want to be very precise here. These allegations are documented in federal court filings, and it hasn’t been approved in court. It’s also been reported by multiple industry sources, including Fierce Pharma. But I’m telling you,what has been reported in legal proceedings, not stating it as an absolute fact because you deserve to know the difference and because I have to protect my license. Now, what do we know for certain?AbbeVee is working on a biologics license application for Armour thyroid through clinical trials called Avantia. This is cited by the AbbeVee corporate statement 2025 Avantia clinical trial for Armour thyroid. A cell of pharmaceuticals has been pursuing BLA approval for NP thyroid for seven years since 2017 and it completed its phase two trials successfully in 2025. They’re now moving Deb (20:15.448)into Phase 3 trials. This is also cited by the Acela Pharmaceuticals CEO statement 2025 seven-year pursuit for BLA approval completed Phase 2 trials moving to Phase 3.RLC Labs, which manufactured WP thyroid, has made no public announcement about pursuing BLA approval and really probably don’t have a plan to do this since they’ve been off the market for some time now. About five years, I think maybe a little longer. Here’s the market manipulation.If only ABBV is successful and obtains a BLA approval for Armour thyroid, that company would effectively have a monopoly on the DDT market. And in pharmaceutical markets, monopolies historically lead to price increases.We’ve seen this pattern over and over again when turning pharmaceuticals acquired Daraprim and raised their price from $13.50 to $750 per tablet overnight. When Myelin raised EpiPen increased prices by 400 % when insulin manufacturers colluded to raise prices in lockstep. This is the playbook.use regulatory barriers to eliminate your competition and then exploit pricing power. For a drug that’s been on the market since the 1800s, guess corporate greed is everywhere. They’re not making enough money on this product already and they’re taking advantage of the rules that they can manipulate their competition by. And here’s what really makes me furious. The American Thyroid Association, the professional organization Deb (22:06.672)representing endocrinologists sent letters to the FDA commissioner on October 8th of 2025 and September 18th of 2025.advocating for continued patient access to DTEs. This is cited in the American Thyroid Association statement and letter to the FDA commissioner dated October 8th, 2025 and September 18th, 2025. The American Association of Clinical Endocrinologists issued a statement on September 9th of 2025 supporting equitable access and personalized medicine for DTE. This was also cited in the American AssociationAssociation of Clinical Endocrinologists, AACE, statement dated September 9th, 2025. Even the medical establishment, which has historically favored levothyroxine, is saying, wait, this is going too far. Patients need access to this medication. But the FDA is moving forward anyway. Why? Well, where does it always lead us? Follow the money trail.Okay, so I need to explain what a biologics license application actually is because this is where the rubber meets the road for what’s going to happen to pricing and availability. What is a BLA?A BLA is a biologics license application. It’s a formal request submitted to the FDA to market a biologic product in the United States. A biologic is defined under the Public Health Service Act section 351 as a product derived from or made using living material, in this case, animal thyroid glands. And this is cited in the FDA definition for biologic products. So they’re putting armor thyroid right Deb (23:57.377)right up with stem cells and exosomes. Think about that. Stem cells and exosomes cost thousands of dollars per application because of how they have to be harvested, stored, freezed, all of that. But we’re talking about a thyroid gland. Good Lord, people.Unlike regular drug applications for synthetic medications which follow a simpler pathway, the BLA process is designed for complex biological products like monoclonal antibodies, vaccines, and gene therapy products. It’s a much more expensive, much more time-consuming process. The BLA processis what manufacturers have to do. And we’re going to talk about that. So according to Reprocell and Forge Biologics analysis of the FDA’s BLA process, here’s what companies need to submit. First, they need to complete a clinical trial data, phase one, two, and three trials, proving safety and efficacy for desiccated thyroid. Haven’t we done that since it’s been on the market since the 1800s? Just saying.This means they have to conduct large randomized controlled trials comparing it to levothyroxine, measuring safety outcomes, efficacy outcomes, and quality of life metrics. Second,Chemistry, Manufacturing and Controls, CMC’s data. Detailed information about how the product is manufactured, quality control measures, stability testing and specifications that must be met for every batch. Third, preclinical and animal safety data. Fourth, labeling and product information. Now, I think we have labeling and product information. Deb (25:53.717)since the 1800s? But just saying. Fifth, they need Pharma Covigilance Plan, a detailed plan for monitoring safety after the product is on the market. Haven’t they had to do that since the 1800s? And they have to have a timeline. And this is the critical part. The FDA’s standard review time for a BLA is 10 months.That’s after the application is deemed complete and accepted for filing. So this is cited by the FDA standard review timeline, BLA submission, and FDA review.Now, before you even get to filing, you need to conduct the clinical trials and compile all the data that’s typically several years of work. How are you going to prove safety and effectiveness in a large clinical trial long term? What do they consider? What do they deem long term? Three months, six months, a year, two years. These companies had 10 months.Well, maybe 12. They did it a year in advance. But unless you knew this was coming, how are you going to put together a trial, enroll the people, have all the trial components set up and ready to go in less than 12 months unless you knew it was coming beforehand? Even ifhad started all their clinical trials in 2024, completing them, compiling the data, and getting a complete application ready for submission, this would likely take you through mid-2026, then add another 10 months for FDA review. We’re looking at 2027 at the earliest for most of these companies to receive a BLA application. Deb (27:54.319)But the FDA gave the manufacturers until August of 2026. That’s approximately 19 months from when the August 2025 letters were sent. Most companies cannot reasonably complete the BLA approval in that timeframe. And when I’m talking about the 19 months, I’m talking about the information they would have had earlier. Now the cost.This gets me even more frustrated. Why are we spending this kind of money? The BLL process is extraordinarily expensive. The current FDA user fee for a BLA submission is approximately $483,560 just for the filing fee. And this is cited at the FDA user fees prescription drug user fee rates for 2025.The full cost of conducting clinical trials, CMC studies, and all the supporting documentation typically ranges from $500 million to over $1 billion, depending on the scope of the trials and the complexity. And this is cited in JAMA’s network, Open2023. A cell of pharmaceuticals has been pursuing the BLA approval since 2017. That’s eight years. And it’s just now.moving into phase three trials with a planned enrollment of approximately 300 patients. This is cited by the Acela Pharmacies CEO statement of 2025. Now that’s unusual. That’s typical for this process. This is not unusual. This is typical for this process to take seven, 10 years to get approval for this. So if Abby’s the one that requested this,Abby V. And Acela started this in 2017. Was Abby V threatened by Acela that Acela might get this approval and it would be quietly done without anybody seeing it? And maybe Abby V would be left out of the market after a century? Who knows? It’s possible. Deb (30:13.112)But for smaller manufacturers without billions in revenue, this cost is completely prohibitive. And this is why this matters. When you push an old established medication through an extraordinary, expensive approval process with a compromised timeline, one of three things happen. First, only the largest companies can afford it, creating a monopoly. And when that happens, the company that holds the only approved product can set pricing withminimal competitive pressures. Two, smaller manufacturers can’t afford it and their products disappear and the market shrinks and access decreases. Three, we see a combination of both and who pays the price? Literally, patients do. Now here’s whereThere’s something I want you to really think about because this is where the regulatory argument falls apart when you look at it carefully. The FDA’s concern about DTE is that, and I’m quoting their official statement, tablets from the same manufacturing batches may not always provide the same thyroid hormone levels. This is from their FDA statement.And that’s a legitimate quality concern, right? It is. Thyroid medications have a narrow therapeutic window like any other hormone, meaning the difference between an effective dose and the dose that causes problems can be quite small. But here’s what the FDA doesn’t emphasize. Generic drugs have the exact same dosing inconsistency issue, and it’s considered acceptable and has been since we allowed generics on the market.So how does a generic drug dose work anyway? Well, for generic drugs to be approved as bioequivalent to a brand name medication, the FDA requires that the generic drugs bioavailability fall within 80 to 125 % of the brand name product. Isn’t that a dose inconsistency? Deb (32:22.894)from the brand name medication? 800 or sorry, 80 to 125%. According to the pharmacy times analysis of the FDA’s bioequivalent standards, the 80 to 125 % bioequivalence rule means that a generic drug can have 20 to 45 % variability compared to the original brand product.Now, most generics are much closer than that. The FDA study data shows that the mean difference for an AUC value between generic and reference products is about three and a half percent in the two year post-Waxman hatch period, and 80 % of the generics fall within a five percent range. But the FDA’s regulations allow for that much higher variability. And this is cited in an FDA study data mean difference for AUC.Now, let me put this in plain language. A patient could take a generic levothyroxine tablet where one batch provides, say, 75 micrograms of an active thyroid hormone. And the next batch from a different manufacturer, a different generic manufacturer, could provide up to 93.75 micrograms, 125 % of that 75. That’s an 18 microgram difference.in the same prescribed dose. Now, this is considered acceptable and patients tolerate it and this system works.Yet the FDA’s argument against DTE is that batch-to-batch inconsistency is unacceptable and requires this expensive biologic approval? That’s a double standard. So why is batch inconsistency acceptable for generic levothyroxine, but supposedly unacceptable for desiccated thyroid? I’ll give you the regulatory answer. Deb (34:29.366)because DDT is a biological product derived from an animal tissue and the FDA considers biological products to require more rigorous control. That’s the regulatory answer, but I’ll give you the real answer.because there’s no billion dollar pharmaceutical company with a patent pending on generic levothyroxine who petitioned the FDA to regulate their competitors more strictly. The inconsistency argument is legitimate, but it’s selectively applied. And that matters when you’re trying to understand whether this is really about patient safety or whether it’s about market control.Now I want to talk about something that hasn’t gotten nearly enough attention in this discussion and it’s something that makes me absolutely furious. What is Armour Thyroid? According to the official prescribing information published by AbbeV and available through rxabbev.com and the FDA’s daily med database, Armour Thyroid contains the following inactive ingredients. Calcium steroid,dextrose derived from corn, mycocrystalline cellulose,sodium starch glycolate and a opadri white coating. Now let’s talk about dextrose. Dextrose is a sugar derived from corn and while manufacturers claim that the corn derived dextrose in armor thyroid is gluten free, here’s the problem. Cross contamination during corn processing can introduce gluten proteins especially if the corn is processed in facilities that also handle Deb (36:18.808)wheat, barley, or rye. Corn sensitivity is extremely common in patients with celiac disease and non-celiac gluten sensitivity, and studies show that up to 50 % of the celiac patients react to corn proteins due to molecular mimicry, and the corn proteins look similar enough to gluten that the immune system attacks them. And this is cited by RestartMD.com.And here’s what’s documented in peer-reviewed medical literature in a 2023 case report published in Case Reports in Endocrinology. These researchers documented five patients with gluten intolerance or celiac who were taking natural desiccated thyroid. Three of those patients also reported lactose intolerance. Now these patients had to switch from DTE to liquid levothyroxine formulations to avoid the inactiveSo here’s my question. If AbbeV becomes the only manufacturer with an approved DTE product and their formulations contain corn-derived dextrose that triggers reactions in celiac patients, what are those patients supposed to do? They can’t take armor because of the corn. They can’t take compounded DTE because the FDA is banning compounding of these biologics. They can’t take NPKsor WP thyroid because those companies may not survive the BLA process. So they’re left with a synthetic version of levothyroxine which may not work for them.Now the NP thyroid and WP thyroid difference. Now here’s what’s interesting according to drugs.com comparison of inactive ingredients and P thyroid and P thyroid has calcium steroid dextrose also derived from corn, mineral oil, multi-crystalline cellulose. Deb (38:19.31)cross carmelicin sodium and a opadri to white. So NP thyroid also has corn-derived dextrose. WP thyroid on the other hand was specifically formulated to be hypoallergenic according to ROC labs, but it’s no longer available and its ingredients were inulin from chicory root and medium chain triglycerides. No corn, no gluten, no common allergies. So todayWe do not have a glandular thyroid, a DTE, that is not potentially contaminated with gluten. Yet, patients with autoimmune thyroid disease are supposed to avoid gluten.Now, some of these people can handle a DTE and many cannot, so that argument could be a mute point. But at the end of the day, the one product that we had that was designated for patients with multiple chemical sensitivities, celiac disease and coron allergies, has been off the market for a long time already.We have a monopoly problem. So if ABBV becomes the only approved manufacturer, patients with these celiac diseases and corn allergies will either be forced to take a medicine that makes them sick and triggers their immune reaction or switch to a synthetic that doesn’t adequately treat their hypothyroidism or choose to go without treatment. This is not hypothetical. This is real patients with real medical needs who are about to lose accessto the only formulation that works for their body. And the FDA’s response is silence. Deb (40:07.69)Now I want to highlight something that hasn’t gotten nearly enough attention in this discussion. Compounding pharmacies. What is a compounding pharmacy? Compounded medications are custom made by licensed pharmacists to meet a patient’s specific needs. Maybe you need a different strength that was commercially available, but you have an allergy to a filler or a dye in the commercial product. Maybe you need a liquid formulation or instead of a tablet or you need a capsule. That’s when compoundingin. And the FDA’s, this is the FDA’s definition of compounding. And for decades, compounding pharmacies have been making desiccated thyroid extract for patients who needed customization. Some patients couldn’t take the commercial products because of the dyes and the fillers, and some needed strengths that were not available. And these compounding pharmacies filled the gap.But reclassification changes everything. When the FDA reclassified DTE as a biologic in 2022 and reinforced that decision in August of 2025, explicitly stated, and I’m quoting directly from the FDA’s official statement, these unapproved animal-derived thyroid medications are not eligible for compounding because these products are regulated as biologic products under the Public Health Service Act.How can that be? These products have been approved since 1938 and the Biologics Act didn’t go into effect or doesn’t go into effect until August of 2026.So how in 2022 were they able to say that the compounding pharmacies could not make these products? Anyway, what this means is after August 2026, compounding pharmacies will no longer be permitted to compound a desiccated thyroid extract, even for patients with specific medical needs. Now, compounding pharmacies can still compound T4 and T3 separately, synthetic versions of levothyroxine and liothyronine, according to Deb (42:12.728)healing dose compounding pharmacy. These pharmacists can create custom ratios of these two synthetic hormones to approximate what a patient was receiving from a DTE. But that’s not the same thing. Some patients respond better to the whole DTE preparation than to a compounded synthetic combination. And for patients with specific allergies to standard fillers like your celiac patients that I just talked about, losing the ability to get a compounded DTE alternative isreal hardship. This is going to be a ripple effect. For a subset of patients, maybe 5 to 10 percent of those on DTE compounding was their lifeline and it was their way to get a medication formulation that worked for their unique body. When compounding goes away, these patients lose that option as well and for some it will be a significant problem. Now let’s talk about what this likely means for your wallet.The current pricing right now, according to SingleCare and GoodRx, Armour Thyroid costs approximately $150 to $157 for a 90-day supply of 60-milligram tablets, about $1.67 per tablet. With discount cards, some patients can get it down to $101 to $152 for a 90-day supply.Generic levon thyroxine costs about $70 for a 90 day supply, less than half that price. And p-thyroid costs approximately $133 for a 90 day supply of 60 milligrams with a discount card about $83 to $101.What happens after we get BLA approval? Well, here’s the pharmaceuticals pricing model. When a company spends 500 million to $1 billion to bring a product to market, including conducting massive clinical trials, the cost tens of millions of dollars they recoup in that investment through pricing power. And this is cited in the pharmaceutical pricing models. If ABBIEV is the only company with an approved BLA of DTE, Deb (44:18.248)They have pricing power. They don’t have competitors. They can set their price, whatever they want. And historically, when drugs transition from grandfather status, which is basically unregulated to formal formally approved status, prices often increase significantly, not always, but often. And typically they have to get re-approval for insurance. SoTouring Pharmaceuticals acquired DARPM and raised the price again from $1,350 to $750 overnight, a 5,000 % increase. This is the playbook.Let’s talk about insurance coverage. This is the other consideration. Insurance companies sometimes have different coverage policies for approved versions versus unapproved drugs. And right now, many insurance plans cover armor thyroid or NP thyroid, even though they’re technically unapproved because they’ve been on the market for decades and patients are on them. Once a drug becomes formally approved, insurance companies may have new contractual relationships, prior authorization requirements, or preferred drugs.list that could affect your coverage. If 1.5 million people have to get a prior auth for their insurance to cover this new medication, this is going to drive the doctor’s offices crazy. We do not have the staff to man this. We do not have the manpower. We do not have the time. This is going to interrupt people’s ability to get their medications. This is going to create chaos within the system. And some patients might see better coverage, but manymost likely are going to see worse coverage and some might find themselves in a situation where they need to try to get the drug approved first or get an approval for something else like levothyroxine and they’re going to have to document that it didn’t work and the documentation that they had from 20 years ago is probably not going to be enough because it’s not documented anywhere. It’s lost in the system after 10 years. So for patients the practical takeaway is expect Deb (46:25.774)a price increase. I would say possible, but I don’t think that’s true. think you’re going to see a price increase if they get approved. Expect possible insurance complexities, budget accordingly, talk to your insurance company now about what your coverage is going to look like in 2027 if they even know. And if you want my honest assessment of what is likely to happen,I’ll give you a scenario, 30 % likelihood. The FDA enforces the August 26 deadline and DTE products not approved by then are pulled from the market. Patients will have 30 to 90 days to transition to other medications. Some patients suffer significant symptom relapse. Compounding for DTE becomes illegal and this disruptiveness of the system creates a real hardship. Scenario two.which is 50 % likely. This is actually what the FDA commissioner, Marty McCreary suggested on August 13th of 2025 when he posted on social media. The FDA is committed to pursuing the first ever approval of desiccated thyroid access pending results of the ongoing clinical trials. In the meantime, we’ll ensure access for all Americans. Hopefully that continues. What this likely means is the FDA uses enforcement discretion to allow continuedsales while approvals are being pursued and the deadline gets extended. Maybe patients get access for another two to three years while companies work on a BLA approval. This would be the least disruptive scenario, but it’s also legally uncertain because the enforcement letters have been formally rescinded. And scenario three, which is 20 % likelihood, one or two companies get BLA approval. Those products stay on the market at higher product prices and companies, products, other companiescompanies, products are pulled, the market shrinks, availability is limited, prices are higher, but patients can still get something. This is likely if a seller successfully completes phase three trials for NP-thyroid. And my assessment is based on the regulatory language and the enforcement letters that have not been rescinded yet, that the pattern of FDA enforcement, I believe scenario two enforcement discretion with an extended time frame is most likely what we’re going to see. Deb (48:49.488)doesn’t mean patients should sit back and do nothing. It means you should be prepared for change while advocating for access. If you want to keep Arm or Thigh Right on the market, 1.5 million people need to start talking about this publicly and flooding our Congress people, Bobby Kennedy, the FDA, with what you want to see happen. We have the ability to shape this and to change this with our voice. But if we sit back on our laurels and we do absolutelynothing. What is going to happen is what the FDA wants to have happen and ABV wants to have happen because they’re going to simply think people don’t give a shit. And if the American people are going to be lazy and not want to step forward and actually start using their voice for some good and instead of just going to social media and bitching and hoping something is going to happen, well, then we’re going to get what we deserve. But if you start taking someaction and you start advocating for the things that you want. Contacting your representatives, contacting your U.S. tell them the FDA has done this. Many of them may not know this, may not be on their radar. Tell them what you want. Start going after this. Start writing to the FDA Commissioner’s Office. They have a website. They have a Commissioner’s Office at fda.hhs.gov. Be responsible.respectful, but be firm. Explain your scenario. How long you’ve been on DTE. Why levothyroxine doesn’t work. What symptoms you experience when not adequately treated. How this decision will affect your quality of life and your pocketbook. Let’s do something proactive. So let’s consider this. Moving forward, work with your provider who understands the regulatory landscape around DTE. You can discuss the evidence for and against combination therapy.You can monitor for thyroid function with free T3 and free T4 testing, not just TSH. If you’re willing to try individualized approaches, you can do that. If you need help finding a functional medicine provider who understands this issue, come to serenityhealthcarecenter.com or explorethevanari.com. It’s a self-directed functional medicine support group. And right now what is happening is going to shape how history Deb (51:19.024)is made with not just armor thyroid, but many drugs to come. And it is important for you to take action. So I want to thank you for joining me today on Let’s Talk Wellness Now. This episode is about far more than thyroid medication. It’s about your right to personalized medical treatment. It’s about your regulatory capture and corporate influence. And it’s about what happens when billion dollar companies shape healthcare policy in ways that reduce patient choice and increase their profits.this episode resonates with you or you know somebody who’s going to be affected by desiccated thyroid, please share it. Post it on social media, send it to your doctor, email it to your representatives, tag AbbeVee, tag FDA. Make noise because the only way we stop this is if we make it too politically costly for them to continue. Your voice truly matters. Your health truly matters and you deserve access to treatments that work best for your unique body.If you’re ready to explore comprehensive personalized health care that puts you in control, visit us at SerenityHealthCareCenter.com. Learn more about functional medicine approaches to thyroid and beyond and explore my new platform, Venari.com, which is a self-directed functional medicine tool. Thank you for joining me today. Until next time, I’m Dr. Deb reminding you, your health is your responsibility, your choice, and your right. Be well, stay informed, fight back.and I’ll see you in the next episode. And if you’re looking for a full citation list of this episode, you can head over to letstalkwellnessnow.com and I will post all the citations for you so you have them in your arsenal as well. Thank you again.The post Episode 259 – The Desiccated Thyroid Crisis: FDA's Unseen Impact & Corporate Manipulation first appeared on Let's Talk Wellness Now.

Full article: https://www.ajronline.org/doi/10.2214/AJR.25.34334  The PET/CT examinations commonly obtained in patients with cancer provide additional information that can be used for nononcologic prognostication. Radhika Rajeev, MD, discusses the AJR article by Kim et al. exploring the role of visual ordinal coronary calcium scoring on routine FDG PET/CT examinations in predicting perioperative outcomes.

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/ All of Dr. Morse's and his son's websites under one roof: https://handcrafted.health/ Facebook Page: https://www.facebook.com/handcrafted.health 00:00:00  - Intro - New Capsules! 00:02:01 - Peptic Ulcers - Extreme Fatigue - Wrinkling - Joint Pain - Cold Hands - Poor Digestion - Anxiety 00:41:04 - Acid Reflux - Stomach Issues - Anxiety - Heart 00:54:48 -  Health and Spirituality Question - Stomach Pains 01:14:00 - Calcium for Toddlers 00:02:01 - Peptic Ulcers - Extreme Fatigue - Wrinkling - Joint Pain - Cold Hands - Poor Digestion - Anxiety When I get hungry, I become extremely shaky as if I'm going to pass out if I don't eat. 00:41:04 - Acid Reflux - Stomach Issues - Anxiety - Heart I visit the ER 4 times a week and they are tired of me. 00:54:48 -  Health and Spirituality Question - Stomach Pains What's your opinion on Reiki energy healing? 01:14:00 - Calcium for Toddlers Once I wean my child off breastmilk, I'm concerned she won't be getting enough calcium.

Send Zorba a message!Zorba gives his take on the latest wellness and biohacking trend...peptides. He helps out a caller who has concerns about taking prescription sleep aids. An emailer asks about back pain and if surgery is the correct path, and Zorba talks about the best calcium to take. We hear a mom joke...actually a dad joke from Karl's dad. Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Supplements, supplements, supplements…it seems that everywhere we turn – on social media, in our email inbox, radio ads, on TV and in stores, we're coming across ads trying to persuade us to buy this or that new dietary supplement as a nutrition boost. But which ones are REALLY necessary for our health and which ones are just … ‘hype'?   Let's look at one of these nutrients today – vitamin D. In this episode, we'll explore some of the key roles that vitamin D plays in our body and what current research and findings are showing for this nutrient. I want to help you enjoy the best nutrition and health on a plant-based diet lifestyle. Curious? Let's dive into this together. Meet me on the inside!     Contact -> healthnow@plantnourished.com Learn -> www.plantnourished.com Join -> Plant-Powered Life Transformation Course: www.plantnourished.com/ppltcourse 1:1 Coaching Support -> https://www.plantnourished.com/coachingwaitlist Get Free 15-Minute Strategy Call -> www.plantnourished.com/strategycall Free Resource -> 7 Ways to Test-Drive a Plant-Based Diet: www.plantnourished.com/testdrive     Have a question about plant-based diets that you would like answered on the Plant Based Eating Made Easy Podcast? Send it by email (healthnow@plantnourished.com) or submit it by a voice message here: www.speakpipe.com/plantnourished     [Plant Based Eating, Nutrition, Vitamins, Supplements, Health, Immunity, Bone Health, Calcium, Whole Foods, Plantbased Nutrition, Nutrition Tips, Healthy Eating, Nutrients]

In today's episode, we're diving into the impact of mitochondria on chronic conditions like fatigue, pain, and depression. You'll hear why optimizing basic factors like sleep, movement, and stable blood sugar isn't just “wellness” advice, but can actually be game changers for patients struggling with conditions such as leaky gut, Hashimoto's, fibromyalgia, or neuropathic pain.Datis Kharrazian unpacks the science behind mitochondrial bioenergetics and reveals how even the tiniest steps, like improving circadian rhythm or addressing subtle nutritional imbalances can help untangle the complex web of chronic illness. You'll also learn about the connection between mitochondrial dysfunction, increased pain sensitivity, and how negative neuroplasticity can turn temporary pain into a lasting syndrome. Whether you're a practitioner, a patient, or someone passionate about functional medicine, this episode will empower you to look beyond protocols and focus on the underlying mechanisms that drive recovery.Register for Chronic Fatigue and Pain Syndromes Clinical Strategies and Treatment Applications at https://pages.kharrazianinstitute.com/chronic-fatigue-and-pain-syndromesTo become a Certified Functional Medicine practitioner, visit https://kharrazianinstitute.com/⁠. Try our 7-day free trial, no credit card required. ⁠For Certified Functional Nutrition education for both practitioners and lay people, visit https://afnlm.com/⁠00:00 Circadian Rhythm Improves Recovery09:38 Mitochondria, Calcium, and Chronic Pain10:46 Chronic Pain Linked to ER Stress15:42 Mitochondrial Health Relieves Chronic Pain17:34 "Fibromyalgia Mechanisms and Pain Reduction"21:41 "Functional Medicine Training Resources"Support this show http://supporter.acast.com/solving-the-puzzle-with-dr-datis-kharrazian. Hosted on Acast. See acast.com/privacy for more information.

Heart palpitations don't usually mean heart damage. In this video, I'll uncover the true underlying causes of heart palpitations and share simple heart health tips to address your heart rhythm problems. Download Dr. Berg's Free Daily Health Routine: https://drbrg.co/45qtO07Heart palpitations and heart rhythm problems are an electrolyte issue. Electrolytes are minerals that allow electricity to travel through the nervous system. Unfortunately, doctors rarely look at electrolytes as part of the problem.A magnesium deficiency is one of the most likely causes of heart palpitations. The majority of people with heart palpitations have normal EKG tests and echocardiogram results. If you have chest pains, fainting, or known heart disease, get these symptoms checked.A skipped or extra heartbeat is known as a heart palpitation. This may cause a strange sensation in your chest, cause you to take a breath, or even cause dizziness. This is caused by an unstable electrical rhythm. This does not mean your heart is failing or that you have any structural failure at all. Calcium causes contraction of the heart muscle. Too much calcium can also cause twitches, cramps, insomnia, and anxiety. Magnesium is the master controller of calcium, and the most important electrolyte for nerve stability. A magnesium deficiency rarely shows up in a blood test. When the demand for magnesium increases, you might experience palpitations. The most common trigger for heart palpitations is stress. Magnesium acts as a buffer to adrenaline and cortisol, so the demand increases when you're stressed. In addition to stress, there are many things that can increase the demand for magnesium, including the following:• Poor sleep• Unstable blood sugar• Hormonal shifts• ExerciseMagnesium excretion can also cause magnesium deficiency, leading to heart palpitations. Caffeine, a low-carb diet, heavy sweating, and alcohol can cause magnesium excretion.Simply not getting enough magnesium from your diet or water source can also contribute to heart palpitations. Salad, chocolate, avocado, and nuts are the best sources of magnesium. When you consume ultra-processed foods that are devoid of nutrition, you deplete magnesium. Magnesium glycinate is a highly absorbable form of magnesium that can help increase GABA and reduce cortisol levels. Start with 400 mg of magnesium daily and increase if necessary. When taking more than 400 mg, spread your doses throughout the day.Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.

Kidney stones form when minerals in urine crystallize and clump together. Among all types, calcium oxalate stones are the most common Calcium oxalate stones were long thought to result solely from physical and chemical processes, but a recent study found that bacteria are embedded inside them These bacteria form dense biofilms within the stone, creating sticky structures that give crystals more places to attach, helping the stone form and grow A separate study showed that kidneys host their own microbiome, where certain bacteria promote stone formation while others help limit crystal growth within kidney tissue Simple steps like staying hydrated, moderating oxalates, reducing seed oils, moving more, and avoiding unnecessary antibiotics can help lower stone risk while supporting kidney microbial health

Let's start your week strong with a quick tip you can incorporate right away. In this Mo's Monday Minute shortie episode, I'm breaking down hypocalcemia causes and complications. See you there! ___________________ ⁠⁠FREE CLASS⁠⁠ - If all you've heard are nursing school horror stories, then you need this class! Join me in this on-demand session where I dispel all those nursing school myths and show you that YES...you can thrive in nursing school without it taking over your life! ⁠⁠20 Secrets of Successful Nursing Students⁠⁠ – Learn key strategies that will help you be a successful nursing student with this FREE guide! ⁠⁠All Straight A Nursing Resources⁠⁠ - Check out everything Straight A Nursing has to offer, including free resources and online courses to help you succeed!

Midlife can feel like your body suddenly changed the rules. The supplements that once boosted energy, hair growth, and metabolism might now be causing bloating, acne, brittle hair, belly fat, dry skin, hormone imbalance, and even abnormal lab results. In this episode, Chalene breaks down the popular supplements many women over 40 are still taking that could be quietly sabotaging their health, thyroid labs, skin barrier, bone density, and hormones. If you're navigating perimenopause or menopause and wondering why you don't feel like yourself anymore, this conversation will challenge what you think you "should" be taking. This is not about fear. It's about testing, not guessing, and making smarter choices in midlife. Check out this video on YouTube